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 In this project we will developed a linear 
regression model to predict the posterior ECG 
lead V7-V12. A physiological interpretation of 
the regression coefficients is given. Furthermore 
we will evaluate different methods to obtain the 
regression coefficients and the precision of the 
point estimation.   
 Thirty-seven healthy persons without any 
history of heart diseases were included. In our 
investigation, we extended the standard 12-lead 
ECG with six posterior leads; three electrodes 
placed on the both side of the back. On each 
subject, 5 consecutive recordings of the 18-lead 
ECG were recorded. 
 In conclusion, we found the pooled method to 
be best performing, and segment wise estimation 
of the ECG signal improves the precision of the 
linear model further. Our results are promising in 
healthy subject, however it is difficult translate 
the results form this study to an assessment of 
the application of the model in AMI patients.  
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Linear model for deriving the posterior ECG leads
V7-V12 in healthy subjects: Part 1
Kartheeban Nagenthiraja
Abstract— In the present study, we develop a linear model to
estimate the posterior ECG leads V 7-V 12 by means of the 8
independent ECG leads in healthy subjects.
Thirty-seven healthy persons without any history of heart
diseases were included. In our investigation, we extended the
standard 12-lead ECG with six posterior leads; three electrodes
placed on the both side of the back. On each subject, 5 consecutive
recordings of the 18-lead ECG were recorded. The subjects
were randomly divided into two groups; a training and a test
group. The ECG recordings of the subjects in training group
were merged to one large data set, and a regression model was
determined. The model was validated by the ECG recordings in
the test group.
The posterior leads V 7-V 9 were predominantly modeled by
the electrical dipole in the horizontal lateral plane. Information
of the electrical diploe in the horizontal anterior-posterior plane
was attenuated in the regression model as a result of the
transformation matrix and the intermediary steps of the best
subset regression.
Modeling of the posterior leads V 10-V 12 by a linear regression
model was possible in healthy subjects with acceptable accuracy
by means of the standard 12-lead ECG. Likewise, the transforma-
tion of leads V 7-V 9, the information in the horizontal anterior-
posterior plane, and in the vertical plane was also attenuated in
the regression model for leads V 10-V 12.
The suppression of the information in the horizontal anterior-
posterior plane in the regression model may question the mod-
els ability to transform possible information in the horizontal
anterior-posterior recorded by the independent leads correctly
to the posterior leads.
In conclusion the linear model developed in the present study
on healthy subjects performed well on healthy subjects, but we
expect this model yield a poor result when applied on patients
with disturbed electrical pathways.
Index Terms— Regression matrix, minimum least square,
dipole model, best subsets regression, 12-lead ECG
I. INTRODUCTION
ST-elevation is one of the clinical findings of acute my-
ocardial infarction (AMI) along with elevated blood troponin
level and chest pain. ST-elevation does not appear in all
AMI patients, despite elevated troponin level and chest pain,
and these cases are termed non-STEMI. Appearance of ST-
elevation highly depends on the location of the thrombus
and the position of the ECG leads in relation to the area of
ischemia. ST-elevation caused by occlusion of left circumflex
artery (LCX) are under-represented compared to ST-elevation
caused by occlusion of one of the two other main arteries;
right coronary artery (RCA) and left anterior descending artery
(LAD) [1].
Higher mortality rates have been reported among non-
STEMI patients in proportion to STEMI patients [2]–[4], and
this is a consequence of under-recognition and under-treatment
of the non-STEMI patients [5].
Several studies have proposed an extension of the standard
12-lead ECG by three posterior leads [6], [7], to improve the
sensitivity of diagnosis of non-STEMI patients. Evaluations of
the standard 12-lead ECG versus 15-lead ECG have yielded a
better sensitivity of diagnosing non-STEMI patients [8]–[12].
The 15-lead ECG is not a standard in health care system and
the placement of the posterior leads in emergency situation
may be impractical.
Mathematical models can be used to estimate the posterior
ECG leads by means of the independent ECG leads. According
to our literature review, only one publication exists concerning
this field. In this study, they proposed a strategy to derive
the posterior leads from the independent leads, for providing
additional information in diagnosing AMI. The model was
entirely based on healthy subjects, and they concluded the
model to yield a satisfactory accuracy according to clinical
criterions [13]. But they did not publish the regression matrix
and their conclusions were mainly based on the output of the
regression model and not based on the interpretation of the
regression matrix. We consider these issues to be the main
disadvantages of the study. Any considerations of how well
their model will perform on non-healthy subjects e.g. patients
with disturbance in the electrical pathways were not given
either.
In this study, we develop a linear model to estimate the
posterior ECG leads V 7-V 12 by means of the 8 independent
ECG leads in healthy subjects. We publish the regression
matrix and our conclusions are entirely based on interpretation
of the regression matrix. We make a theoretical assessment of
how well our model based on healthy subjects will perform
on patients with AMI.
II. METHODS & MATERIALS
A. Data acquisition
In this study ECG recordings from 37 healthy persons with-
out any history of heart diseases were included. Twenty five
subjects were males and 12 subjects were females. The healthy
subjects were recruited from Institute of Health Science and
Technology, Aalborg University and Aalborg Hospital.
In our investigation, we extended the standard 12-lead ECG
with six posterior leads. Three electrodes were placed on
both sides of the back. The 12 standard electrodes were
placed according to existing standards [14] with the subject
in supine position. The electrodes on the back were placed
while the subjects were sitting, without support of the back.
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Training Test
Parameter Mean SD Mean SD p-Value
Female n = 6 n = 6
Male n = 13 n = 12
Age 27.9 yr. ± 4.00 25.2 yr. ± 3.80 >0.05
Height 1.80 m ± 0.08 1.80 m ± 0.10 >0.05
Weight 77 kg ± 11.69 79 kg ± 16.49 >0.05
BMI 23.53 kg
m2




SUMMARIZATION OF SUBJECTS CHARACTERISTICS
The posterior leads V7-V12 were placed as follows; V7: Left
side of the back, over the posterior axillary line in same level
as V5. V8: Left side of the back, over the midscapular line in
same level as V5. V9: Left side of the back, half way between
midscapular line and spine in same level as V5. V10: Right
side of the back, over the posterior axillary line in same level
as V5. V11: Right side of the back, over the midscapular line
in same level as V5. V12: Right side of the back, half way
between midscapular line and spine in same level as V5).
All the recordings were performed with GE MAC 5000 (500
Hz sampling rate) with the subject in relaxing supine position
and with a comfortable breath frequency. Five consecutive
recordings of 10 seconds were acquired.
The data were converted to ascii format for further analysis.
For each recording the ECG monitor provide a median beat
of 1.2 sec duration.
B. Statistical model
In a linear regression of the standard leads to the posterior
leads, the heart can be assumed as a dipole with a fixed loca-
tion and variable orientation and magnitude. The surrounding
tissue e.g. lungs, adipose tissue and bone together can be
assumed as an infinite homogenous conductor [15].
yj(t) = β1x1(t) + β2x2(t) + β3x3(t) + · · ·+ β8x8(t) (1)
where yj is the vector of transformed posterior lead, and
j = 7, 8 · · · , 12. xi is the independent leads, where i =
1, 2 · · · , 8. βi is the regression coefficients. For convenience
the expression in 1 can be written in matrix notation
Y = BX (2)
where matrix Y contains the posterior leads V 7-V 12. B
is the regression coefficient matrix, and matrix X contains
the independent leads. The coefficients of B are estimated by
minimizing the error between the estimated output Ŷ(n) and





In expression 3 the intra-patient variation is neglected, and
the data of subjects in the data base is assumed as a large data
set [16].
The least square solution of the expression 2 is given by
B = (X′X)−1X′Y (4)
The coefficient of determination of the fit is given by
R2 = 1− SSerror
SStotal
(5)
where SSerror is the sums of squares of the difference
between the estimated and the recorded signal, and SStotal is
sums of squares of the difference between the recorded signal
and the mean of the recorded signal.
C. Data analysis
The data analysis was performed in MATLAB (R2007a,
The MathWorks, Inc.). The subjects in the data base were
randomly divided into two groups; a training and a test group,
respectively. The training group was used to develop the
regression model and the test group was used to validate the
regression model.The ECG recordings of all subjects in the
training group were merged into one large data set and were
considered as one data recording.
Prior to developing the regression model, we performed a
pre-analysis of the ECG recordings of the training group. The
pre-analysis contained an analysis of the correlation between
the independent leads and an analysis of the correlation of the
independent leads and the posterior leads.
The regression coefficients and the coefficients of determi-
nation (R2) were calculated according to expression 4 and 5.
The stability of the regression coefficients were analyzed by
step-wise adding more data to the model and determining the
I II V1 V2 V3 V4 V5 V6
I 1
II 0.7818 1
V1 -0.4015 -0.5490 1
V2 0.0264 -0.2589 0.8172 1
V3 0.5752 0.2734 0.3863 0.7645 1
V4 0.8755 0.7396 -0.2224 0.1610 0.7396 1
V5 0.8845 0.9065 -0.5419 -0.2156 0.3808 0.8734 1
V6 0.8380 0.9449 -0.6316 -0.3304 0.2331 0.7638 0.9718 1
TABLE II
CORRELATION COEFFICIENTS r OF THE INDEPENDENT LEADS
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βI βII βV 1 βV 2 βV 3 βV 4 βV 5 βV 6
V7 0.8004 0.9321 -0.7002 -0.4144 0.1362 0.6924 0.9338 0.9866
V8 0.7342 0.8952 -0.7568 -0.4988 0.0272 0.6072 0.8826 0.9567
V9 0.5287 0.7490 -0.8189 -0.6395 -0.2122 0.3715 0.7067 0.8231
V10 -0.6629 -0.4051 -0.2284 -0.5147 -0.7833 -0.7200 -0.5232 -0.3903
V11 -0.8485 -0.587 0.0360 -0.3439 -0.7496 -0.8363 -0.7140 -0.6099
V12 -0.8961 -0.5875 0.1595 -0.2484 -0.6878 -0.8292 -0.7419 -0.6488
TABLE III
CORRELATION COEFFICIENTS r OF THE INDEPENDENT LEADS AND THE DEPENDENT LEADS
regression coefficients for each step. In this particular analysis
all subjects were included.
A best subset regression was performed to find the best
subsets of independent leads which contribute with significant
(p=0.01) amount of information in the regression model.
III. RESULTS
A. Characteristics of study group
In the training group 19 subjects were allocated; 6 females
and 13 males. In the test group 18 subjects were allocated; 6
females and 12 males. The mean age in the training group was
28 years and the mean age in test group was 25 years (p>0.05).
The mean height was equal in both group, while the mean
weight was higher in test group then in the training group, 79
kg and 77 kg, respectively but not significantly (p>0.05). The
higher mean weight in the test group is reflected in the body
mass index (BMI), 24.17 kg/m2 for the test group and 23.53
kg/m2 for the training group (p>0.05), see table I.
B. Pre-analysis
In table II, the correlation coefficients of the independent
leads are given. As expected, the neighboring precordial leads
V 1-V 6 are well correlated ( r≈ 0.8), as well the limb leads I
and II describing the horizontal lateral plane and the vertical
plane respectively, are highly correlated (r>0.8) with the
precordial leads V 5 and V 6.
In table III the correlation coefficients of the independent
leads and the posterior leads are given. Leads V 7 and V 8
are highly correlated with lead II, V 5 and V 6. The posterior
lead V 9 is highly correlated with V 1 and V 6. Lead V 10 is
negatively correlated with all the independent leads, and the
leads V 11 and V 12 are highly negatively correlated with leads
I and V 4. The correlation coefficients are depicted as bars in
figure 1 for better graphical overview.






Correlation coefficients for leads V7−V9






Correlation coefficients  for leads V10−V12
V7 V8 V9
V10 V11 V12
Fig. 1. Graphical presentation of the correlation coefficients of the indepen-
dent leads and the dependent leads. The horizontal dashed red lines indicate
r=0.8
C. Multiple regression model
Table IV shows the coefficients of the regression matrix
for the multiple regression model. Each coefficients in the
columns describes the weighting of the specific independent
lead in the regression model to obtain the dependent leads
(shown in the rows). To obtain the posterior leads V 7-V 9,
the absolute value of the regression coefficients of leads V 5
and V 6 are of greatest magnitude. In determination of the
posterior leads V 10-V 12, the absolute value of the regression
coefficients of leads I , V 5 and V 6 are of greatest magnitude.
The coefficients of the regression matrix are also plotted in
figure 2 for better graphical overview.
The median coefficient of determination R2 between the
recorded and the estimated 6 dependent leads are given in table
V. In column two and three the median and the interquartile
I II V1 V2 V3 V4 V5 V6
V7 0.0580 0.0121 -0.0289 -0.0092 -0.0126 0.0344 -0.3500 1.0947
V8 0.0387 -0.0304 -0.0608 0.0123 -0.0755 0.1060 -0.5717 1.2764
V9 -0.0423 -0.1009 -0.0999 0.0271 -0.1008 0.1345 -0.7423 1.3453
V10 -0.2257 -0.0542 -0.0812 0.0139 -0.0647 0.0794 -0.4287 0.5339
V11 -0.2916 -0.0008 -0.0323 0.0046 -0.0469 0.0380 -0.2363 0.2661
V12 -0.3527 0.0582 0.0038 -0.0131 -0.0086 0.0061 -0.1355 0.1342
TABLE IV
REGRESSION MATRIX OF THE MULTIPLE REGRESSION MODEL
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Transformation coefficients for leads V7−V9
 
 






Transformation coefficients for leads V10−V12
V12V11V10
V7 V8 V9
Fig. 2. Graphical presentation of the coefficients of regression matrix for
multiple regression.
range of R2 for the training group are listed. In column four
and five the same information is given for the test group.
In both groups the highest R2 is obtained for V 7. R2=0.98
for the training group and R2=0.96 for the test group. R2 is
decreasing toward V 9 in both group. For the leads V 10-V 12,
R2 is almost equal between the leads and also between the
groups. The values given in the table are truncated values.
In figure 3 the development of the regression coefficients
(V 5 and V 6) for the posterior leads V 7 and V 10 are given.
The x-axis indicates the number of subject included to deter-
mine the particular regression coefficient. The subjects 1 to
19 is the subjects included in the training group and from 20
to 37 are the subjects from the test group. In the top row the
development of the regression coefficients of the independent
leads V 5 (red) and V 6 (blue) for regression model of lead V 7
are depicted. The regression coefficients seem almost stable
beyond subject number 15. In bottom row (lead V 10) the
regression coefficients converge beyond subject 19 and seem
to become stable beyond subject 32. Only a limited range of
the results form the analysis are given in figure 3.
The best subset regression method was performed on all
posterior leads, and the summary of the best subset regression
models is given in table VI. For lead V 7 the best subset consist
of leads V 1, V 2, V 3 V 4, V 5 and V 6. Addition of the limb






V7 0.98 (1.00-0.95) 0.96 (1.00-0.92)
V8 0.96 (0.99-0.92) 0.95 (1.00-0.87)
V9 0.95 (0.99-0.91) 0.92 (1.00-0.85)
V10 0.81 (0.90-0.71) 0.85 (0.96-0.73)
V11 0.82 (0.92-0.73) 0.86 (1.00-0.72)
V12 0.85 (0.93-0.77) 0.88 (0.98-0.78)
TABLE V
COEFFICIENTS OF DETERMINATION R2 OF MULTIPLE REGRESSION MODEL








Stability of the regression coefficients in lead V7













Fig. 3. The development of the regression coefficients of leads V 5 and V 6
for predicting leads V 7 and V 10.
leads V 8, V 9 and V 10 the best subsets were II , V 1, V 2, V 3,
V 4, V 5, V 6, where as lead I did not contribute significantly
with more information to the model (p<0.01). The best subset
for lead V 11 was II, V 1, V 3, V 4, V 5, V 6, adding leads I
and V 2 did not add significant more information (p<0.01).
The best subset for lead V 12 counted only four independent
leads II, V 2, V 5, and V 6 (p<0.01).
The graphical outcomes of applying the regression matrix,
table IV on the independent leads are given in figure 4 and
5. Figure 4, shows cases of good modeling, where the R2 for
V7-V9 were ≈ 1 and for V10-V12 the R2 were > 0.9. Figure
5, shows cases of poor modeling. For V7-V9 the R2 were <
0.8 and for V10-V12 the R2 were ≈ 0.
IV. DISCUSSION
Under-recognition and under-treatment of patients with pos-
terior infarcts leads to higher mortality rates compared to other
AMI patients. Several studies have reported better sensitivity
by extension of the standard ECG leads with posterior leads.
In this study, we developed a linear regression model to
derive the posterior leads V 7-V 12 by means of the eight
independent ECG leads. Our model is based on healthy males
and females in the range of 21-37 year without any history of
heart disorders.
Lead Best subset R2 F-stat p-value
V7 V1, V2, V3 V4,V5, V6 0.990 8.1 <0.01
V8 II, V1, V2, V3 V4, V5, V6 0.975 29.9 <0.01
V9 II, V1, V2, V3 V4, V5, V6 0.913 114.1 <0.01
V10 II, V1, V2, V3 V4, V5, V6 0.795 27.4 <0.01
V11 II, V1, V3, V4, V5, V6 0.862 164 <0.01
V12 II, V2, V5, V6 0.885 1661.4 <0.01
TABLE VI
IIIIIIIIIISUMMARY OF BEST SUBSET REGRESSION
NOTE: THE CUT-OFF POINT FOR α=0.01 WITH NUMERATOR DEGREE OF FREEDOM OF ONE AND DENOMINATOR
DEGREE OF FREEDOM OF∞, F1,∞,0.01=6.63
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Fig. 4. Example of good modeling where the R2 were > 0.9.



























































































Fig. 5. Example of poor modeling where the R2 were < 0.8.
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A. Performance of the model
In the training and the test group the best median perfor-
mance of R2 for a single posterior lead was obtained for
lead V 7. This was expected as a result of the correlation
coefficient matrix of the independent leads and the posterior
leads, where lead V 7 was highly correlated (r>0.8) with the
independent leads I , II, V 5 and V 6, see table III. Lead V 7
is highly correlated with leads V 5 and V 6 since the close
anatomical placement between the leads. The lowest best
median performance of R2 was observed for lead V 10 in
both groups with R2 = 0.81 for the training group and R2
= 0.85 for the test group. According to figure 1, the posterior
lead V 10 was the only posterior lead which was not highly
correlated with any of the independent leads, and this could be
an explaining factors of the poor best median performance of
lead V 10. The stability of the regression coefficients may also
have impact on the performance on the model, and in figure
3 we saw the regression coefficients of V 5 and V 6 predicting
V 7 were stable beyond subject 15. However the regression
coefficients of V 5 and V 6 predicting V 10 were converging
beyond subject 19, i.e this particular model developed by
means of the training group was maybe instable. In general
the interquartile ranges of the test group are larger then of
the training group. When the model was applied to a set
of data, which was not used to develop the model, then the
model performed with more extreme outcomes. We suppose
this observable fact was attributed to the minimum least square
method used to derive the expression of the coefficient matrix,
expression 4.
In the regression model, expression 2, an intercept was not
included. Figure 5 shows an example of poor modeling. We
see the model is under estimated in order to the measured
signal e.g. for lead V 10. With implementation of an intercept
in the regression model an improvement of the performance
may be obtained, however a physiological interpretation of
the intercept is meaningless and therefore not included in this
study.
B. Interpretation of regression matrix
The regression coefficients of the multiple regression model
yielded the magnitude and direction of the eight dimensions
that described each single posterior lead. An intuitive in-
terpretation of the eight coefficients simultaneously was not
possible, whereas a stepwise and a pairwise interpretation of
the coefficients would yield the resultant vector of a single
posterior lead. As an example; consider the independent leads
V 5 and V 6. In table III both leads are positively correlated
with lead V 7, however in the multiple regression model they
appear with opposite signs. A geometrical interpretations of
the coefficients for lead V 5 and V 6 are given in figure 6. The
blue and the black vectors are the measured vectors of lead V 5
and V 6, respectively. The green vector is the measured vector
of lead V 7. The regression coefficient of lead V 6 (see table IV)
is ≈ 1.1 i.e. an extension of lead V 6 in order to determine V 7,
depicted as a dashed black vector in figure 6. The regression
coefficient of lead V 5 is ≈ -0.4 i.e. a reduction of lead V 5
in order to determine V 7, depicted as a dashed blue vector.
The resultant vector (green) of the blue and the black vector is
the geometrical estimation of lead V 7. The resultant vector is
not identical with the measured vector in neither direction nor
magnitude. Interpretation of the remaining leads in the same
manner will yield a improved approximation of the measured
posterior lead for each step.
The posterior lead V 10 represented a reduced mirror image
of all the independent leads while the posterior leads V 11
and V 12 also represented reduced mirror images of all the
independent leads except lead V 1. However, this fact was not
directly interpretable from the regression coefficients (table
IV), but it was obvious form the correlation coefficients in
table III. In figure 4 bottom row, the P, QRS and T-waves are
inverted. These results were in agreement with the theoretical
assumption of how the electrical dipole of the heart acts on
opposite placed electrodes.
C. Best subsets
In best subset regression, the independent lead I did not
enter into any of the best subsets, see table VI, and furthermore
the independent leads V 5 and V 6 were included in all the best
subsets. Consider the correlation coefficients of the posterior
lead V 7 and the independent leads (figure 1), we find lead
I to be better correlated with the lead V 7 than the leads
V 1-V 3. However these leads entered into the best subset
of V 7, while lead I did not. The geometrical interpretation
of lead I is the electrical potential difference between the
right arm and left arm (i.e. vector pointing toward left arm)
in the horizontal plane. Consider the model in figure 6, the
electrical potential difference from the right arm to the left
arm in the horizontal lateral plane may already be represented
in leads V 5 and V 6, and this supposition was supported by
the results in table II. Lead I was highly correlated with leads
V 5 and V 6 and, therefore lead I may not provide further
information to the model in the horizontal lateral plane. The
independent leads V 1-V 3 were poorly correlated with lead
V 7, however they described the electrical dipole of the heart
in the horizontal anterior-posterior plane. Leads V 1-V 3 were
therefore included in the best subset for lead V 7 because they













Fig. 6. Geometrical interpretation of regression coefficient of independent
leads V 5 and V 6, in the horizontal plane.
DEPARTMENT OF HEALTH SCIENCE AND TECHNOLOGY, AALBORG UNIVERSITY 7
D. Application of the model on AMI patients
The posterior leads V 7-V 9 were predominantly modeled by
the electrical dipole in the horizontal lateral plane. Information
of the electrical dipole in the horizontal anterior-posterior
plane was attenuated in the regression model as a result of
the regression matrix IV and the intermediary steps of the
best subset regression (data not shown).
In clinical practice the independent leads II, V 3 and V 4 are
used in the diagnosing procedure of posterior infarcts. Lead
II is inspected for ST-elevation and leads V 3 and V 4 are
inspected for ST-depression [17], [18]. Although appearance
of ST-elevation/depression in these leads are not present in all
patients with posterior infarcts, it is still a useful routine in
clinical practice. The underlying cause of the ST-depression
in V 3 and V 4 is a local dipole which is generated in the
area of ischemia, see figure 7. This local dipole’ anode is
pointing toward V 7-V 9 and the cathode is pointing toward
V 3 and V 4, causing the depression in the ST-segment of the
independent leads. By the same way inferoposterior infarction
can produce a downward angled (vertical) local dipole and
cause ST-elevation in lead II [17]. The knowledge of ordinarily
use of the independent leads II, V 3 and V 4 taken together with
the interpretation of the regression matrix lead us to conclude
that, any clinical valuable information concerning posterior
infarction contained in the horizontal anterior-posterior plane
and in the vertical plane are suppressed in the regression
model. This may question if the use of a linear regression
model developed on healthy subjects is suitable in patients
with disturbed electrical pathways. The assumption we did
about the heart as a fixed dipole, may be restricted when
applied on AMI patients. In AMI patients presence of more
than one dipole must be expected. A local dipole induced by
the area of ischemia would appear, and then the single dipole
model of the heart differs from the real property of the heart
with ischemia. And the lacking publication of the regression
matrices in similar studies makes it impossible, directly to
compare the coefficients obtained in the different studies.
In this study, we extended the posterior ECG leads on the
left side of the back with three additional leads on the right
side of the back. According to our knowledge this has not
been described earlier. Any posterior infarction will cause an
elevation of the ST-segment in leads V 10-V 12, as a result
of the mirror image effect, was hypothesized. The possibility
of reconstructing the posterior leads V 10-V 12 with a linear
model in healthy subjects with an acceptable accuracy was
verified in this study. Likewise the regression of leads V 7-
V 9 the information in the horizontal anterior-posterior plane
and in the vertical plane was also attenuated in the regression
model of leads V 10-V 12. The clinical value of these leads
has not been evaluated elsewhere, hence it is not possible to
assess the importance of these leads in clinical practice.
The concept of this study was to provide the physician
in emergency departments with further information about the
electrical conduction of the heart with existing standard ECG
systems. The concept is simple, and the derived information
has significant clinical value [8]–[12]. However, the model of









Fig. 7. Schematic presentation of the local dipole induced by ischemia and
its impact on the posterior leads, in the horizontal plane
adaptable in patients with AMI. To achieve the objective to
reconstruct the posterior leads by means of the independent
leads, we suggest a model with more then one dipole and
variable location of the dipole. Our results intimate that
assuming a heart with disturbed electrical pathways as a dipole
with a fixed location and variable orientation and magnitude
is too simplified. Including both healthy subjects and patients
with AMI in the training group, may result in a more robust
model for the posterior leads.
In conclusion, the linear model developed in the present
study on healthy subjects performs well on healthy subjects,
but we expect this model to yield a poor result when applied
on patients with disturbed electrical pathways. The model
assumed in this study, only fits persons without any electrical
pathway disorders of the heart. More complex models are re-
quired to estimate the posterior leads in persons with electrical
pathway disorders of the heart, by means of the standard 12-
lead ECG.
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Linear model for deriving the posterior ECG leads
V7-V12 in healthy subjects: Part 2
Kartheeban Nagenthiraja
Abstract— In this study, we examined the effects of modelling
the regression coefficients by two different methods. 1) The first
method (average model) was based on patient-specific models and
the regression coefficients were an average of the patient-specific
models. 2) In the second method (pooled model) the regression
coefficients were determined on pooled data. We also suggest a
method to improve the accuracy of the point estimation of the
posterior leads.
The data used in this study contained 19 subjects. For each
subject the standard 12-lead ECG and additional six posterior
leads were recorded. For each subject an individual, regression
model for predicting the posterior leads V7-V12 was determined.
The regression coefficients of the average model were an average
of the 19 individual regression models. The performance of the
average model was determined and compared to the performance
of the pooled model from our previous study. For the improve-
ment of the point estimation the ECG data was segmented in
three segments; P-wave, QRS-complex and T-wave, and partial
regression models were developed.
For the average method the median R2 for all the posterior
leads are lower compared to the pooled method and the in-
terquartile range are wider for the average method. In both
methods the highest R2 is obtained for V 7. R2 = 0.98 for the
pooled and R2 = 0.58 for the average method. The median
residuals of the partial regression models are generally closer
to 0 than for the global model. And the interquartile ranges of
the partial models are narrower compared to the interquartile
ranges of the global model.
In conclusion, the method of pooled data was less noise
sensitive compared to the average method. Modelling the ECG in
segments yield an improvement of the point estimation compared
to the global regression model. With reference to our results it
is not possible to reject the concept of using linear regression
models to predict the posterior leads V 7-V 12 on AMI patients.
Index Terms— Average model, pooled model, reduced lead set,
partial regression models
I. INTRODUCTION
Studies have proposed linear regression models for predict-
ing the posterior ECG leads V 7-V 12 by means of the standard
leads [1], [2]; however the conclusions of the studies were not
in agreement concerning the application of the models on AMI
patients. Wei determined the regression model of the posterior
leads V 7-V 9 as an average of 68 individual regression models
of healthy subjects. We proposed a similar study based on
ECG recordings from 37 healthy subjects, and besides the
posterior leads V 7-V 9, we extended the ECG recordings
with three additional leads on the right side of the back,
termed V 10-V 12. Our regression model was based on pooled
data. Both studies were proof of concept and despite the
fact of two different methods, they both achieved acceptable
accuracy between the estimated and the measured posterior
leads V 7-V 9 (V 10-V 12). Wei declared a positive attitude for
application of the regression model on AMI patients based on
the similarity measurements of the estimated and the measured
posterior leads in healthy subjects. Whereas our assessment
of the application of the linear regression model in AMI
patients was more sceptical, concerning the fact that the model
considers the heart as a dipole, and this might not be the fact
in AMI patients.
In this study, we will examine the two methods of modelling
the regression coefficients mentioned above; 1) by averaging
the patient-specific models and 2) by determining the regres-
sion model based on pooled data, with regard to the regression
coefficients and the coefficient of determination (R2).
The regression models developed in both studies mentioned
above are based on the entire ECG signal including P-wave,
QRS-complex and T-wave and the iso-electric line between
the waves. Henceforward these models will be termed global
regression models. By visual inspection differences in the
P- and T-waves of the estimated and measured signals were
observed, while the differences in QRS-complexes of the
estimated and measured signals were insignificant, despite
larger magnitude range in the QRS-complex. In the ECG
signals the QRS-complexes are relative strong in magnitude
compared to P- and T-waves, especially in leads I , II and
V 4-V 6. The property of the minimum least square estimator
is to find the best regression line in a given n dimensional
space that minimizes the mean squared error. P- and T-waves
may not be well described by the regression matrix because in
order to minimize the mean squared error, the regression line is
mainly fitted to the data points of QRS-complex. By modelling
the three segments P-wave, QRS-complex and T-wave in three
independent models may improve the point estimation of the
posterior leads. These models are termed partial regression
models.
In this study, we examined the effect of modelling the
regression coefficients of method 1 and 2 in terms of the mag-
nitude of the regression coefficients and R2, and we suggest
a method to improve the accuracy of the point estimation of
the posterior leads.
II. METHODS & MATERIALS
A. Data
The data used in this study contained 19 subjects of the 37
subjects initially enrolled in the ECG database. The subjects
in the subset are randomly chosen and are identically with
the training set used in [1]. The subset of 19 subjects was
used for the purpose of being able to compare the results of
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our previous study and the present study. Data acquisition and
summarization of subject characteristics are described in [1].
For each subject the standard 12-lead ECG and additional six
posterior leads were recorded. Three electrodes were placed
on both sides of the back. In the modelling procedure only
the pre-defined eight independent leads were used (I , II , V 1-
V 6). The data analysis was performed in MATLAB (R2007a,
The MathWorks, Inc.).
B. Average model
For each subject an individual regression model for pre-
dicting the posterior leads V 7-V 12 was determined. The
final regression model was an average of the 19 individual
models. Dispersion plots of the regression coefficients for
the independent variables were generated for the purpose of
analyzing the stability of the individual regression coefficients.
For each recording of the six posterior leads the R2 was
determined and the median R2 and the interquartile range of
all R2 were found.
To examine the noise sensitivity of the average method the
number of independent variables was reduced from eight to
three (these models will be termed "reduced average models").
In the example given in this study, we made two models to
predict the posterior lead V 9. The first model contained the
independent variables; V 1, V 5 and V 6. All the independent
variables are highly correlated (r > 0.8) with V 9, and the
leads V 5 and V 6 are highly inter-correlated [1]. In the second
model, the independent variables V 1, V 4 and V 6 are non-
correlated (r < 0.8), but they are highly correlated with the
dependent variable V 9 [1].
C. Global model vs. partial models
To obtain a better point estimation of the posterior leads,
the ECG’s of the subset were segmented into P-waves, QRS-
complexes and T-waves, with respect to all leads. The seg-
mentation algorithm is described in [3]. The P, QRS and
T segments were pooled into large data sets, in correct
subject order for the 14 leads. The improvements of the
point estimation between the global model and the partial
regression models were quantified by residuals. The residuals
of the measured and the globally estimated posterior leads
were determined for each segment and each lead. Likewise,
the median residuals and the interquartile range of the residuals
of the partial estimated posterior leads and the measured leads
were found. The use of the residuals and not the R2 to quantify
the improvements will be discussed later. To test the equality
of the residuals of the global regression model and the partial
regression models, a Signed-Rank test was used.
III. RESULTS
A. Average model
The regression coefficients of the average regression model
are given in table I. The magnitudes of the coefficients are also
depicted as bars in fig. 1. When predicting the posterior leads
V 7-V 9, the absolute value of leads V 6 is of the greatest mag-
nitude, while the absolute magnitude of the other coefficients
of the independent variables are considerably lower compared
to the magnitude of coefficients of V 6. When predicting
the posterior leads V 10-V 12, the absolute magnitude of the
regression coefficient of lead I is of the greatest magnitude.












Regression coefficients for leads V7−V9, average model












Regression coefficients for leads V10−V12, average model
V8 V9V7
V10 V11 V12
Fig. 1. The regression coefficients for the average model.
In fig. 2, the 19 different coefficients for the independent
variables for predicting the posterior leads V 7 and V 10 are
given. The highest dispersion of the coefficients is seen for
the leads V 3-V 6. All coefficients for predicting the posterior
lead V 7, except for lead V 6, are placed about zero and the
coefficients can either be positive or negative. For predicting
the posterior lead V 10, all coefficients can be positive or
negative.














Dispersion of the regression coefficients of V7
















Fig. 2. The dispersion of the regression coefficients for predicting the
posterior leads V 7 and V 10.
The median R2 of the measured and the estimated posterior
leads are given in table II. In column two and three the median
and the interquartile range of R2 from the pooled method
are listed (data from [1]). In column four and five the same
information is given for the average method. For the average
method the median R2 for all the posterior leads are lower
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βI βII βV 1 βV 2 βV 3 βV 4 βV 5 βV 6
V7 0.0811 0.0453 -0.0517 -0.0015 0.0128 -0.1048 0.0785 0.6580
V8 0.0797 0.0591 -0.0969 0.0345 -0.0416 -0.0999 -0.0489 0.7151
V9 0.0072 0.0643 -0.1438 0.0738 -0.1129 -0.0509 -0.2547 0.7611
V10 -0.2850 -0.1304 -0.1396 0.0712 -0.1280 0.0364 -0.2427 0.5339
V11 -0.3370 0.1343 -0.0774 0.0185 -0.0493 0.0081 -0.1512 0.0684
V12 -0.3936 0.1463 -0.0273 -0.0151 -0.0008 0.0037 -0.1411 0.0652
TABLE I
REGRESSION MATRIX, AVERAGE REGRESSION MODEL
compared to the pooled method and the interquartile range
are wider for the average method. In both models the highest
R2 is obtained for V 7. R2 = 0.98 for the pooled and R2 =
0.58 for the average method. The values given in the table are
truncated values.
In fig. 3, the results of the analysis of reduced average
models are presented. The first column presents the average
regression coefficients and the dispersion of regression co-
efficients for the model including the independent variables
V 1, V 5 and V 6. The second column presents the results for
the model including the independent variables V 1, V 4 and
V 6. In the model with non-correlated independent variables
(second column), the magnitude of the regression coefficient
for V 1 and V 6 are smaller and the dispersion of the regression
coefficients is likewise smaller compared to the model with
the correlated independent variables. For the model with
correlated independent variables the median R2 was 0.50 and
the range was 0.87-0.13. In the model with non-correlated
independent variables the median R2 was 0.49 and the range
was 0.83- 0.15. Both reduced average models were performing






V7 0.98 (1.00-0.95) 0.58 (0.97-0.19)
V8 0.96 (0.99-0.92) 0.52 (0.91-0.14)
V9 0.95 (0.99-0.91) 0.40 (0.75-0.05)
V10 0.81 (0.90-0.71) 0.32 (0.68-0.00)
V11 0.82 (0.92-0.73) 0.31 (0.66-0.00)
V12 0.85 (0.93-0.77) 0.30 (0.61-0.00)
TABLE II
R2 OF THE POOLED AND THE AVERAGE METHOD.
In fig. 5, an example of estimating the posterior leads by
the pooled method is given (data from [1]). In fig. 6 the same
recording is estimated by the average method (coefficients of
table I). The estimation by the average method is obviously
poorer than the pooled method in fig. 5. Apart from the
amplitude discrepancy, also the morphology of the ECG’s is
different. Especially the synchronization of the T-wave in the




























































Dispersion of the regression coefficients of V9
Fig. 3. The average magnitude of the regression coefficients and the
dispersion of the regression coefficients of the reduced average models. In
the left column the results of the model with correlated independent variables,
and in the right column the model with non-correlated independent variables.
B. Global model vs. partial models
In fig. 4, the results of the simple regression of the leads
V 5 and V 7 are given. The upper left subplot shows the output
of lead V 5 against the output of lead V 7. The dashed line
indicates the best model for the predicting V 7. The three other
subplots show the output of lead V 5 against output of lead
V 7 when segmented. The dashed line indicates the model
developed on the entire ECG’s, and the solid lines indicate
the models developed on the segments. For P- and T-wave the
discrepancy between the partial model and the global model is
noticeable, while for the QRS segment the two models appear
to be similar. Only the results for V 5 and V 7 are shown.
In table III, median residuals and the interquartile ranges for
the global regression model and the partial regression models
are given. In column 3, the median residuals (global model)
for the three segments with respect to the posterior leads are
given, and in column 4 the corresponding interquartile ranges
are given. In column 5-6, the same information for the partial
models is given. The results of the Signed-Rank test, the test
of equality of the distributions of the residuals from the global
model and the partial models are given in column 7.
The results of table III are given in fig. 7 for better graphical
overview. The median residuals of the partial models (solid
lines) are generally closer to 0 than for the global model (given
as dashed lines). The interquartile ranges of the partial models
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Pooled Average
Lead Median (Range) Median (Range) p-value
P -10.24 (-26.91-6.43) -0.13 (-3.67-3.40) p < 0.05
V7 QRS -10.32 (-124.79-104.14) -1.54 (-11.55-8.48) p < 0.05
T -24.68 (-59.23-9.85) -0.68 (-6.24-4.88) p < 0.05
P -9.61 (-26.48-7.25) -0.20 (-3.98-3.58) p < 0.05
V8 QRS -11.82 (-115.96-92.31) -4.60 (-20.63-11.43) p < 0.05
T -11.91 (-36.77-12.93) -2.29 (-9.28-4.69) p < 0.05
P -3.07 (-15.65-9.50) -0.54 (-5.54-4.46) p < 0.05
V9 QRS -2.68 (-94.96-89.59) -4.34 (-26.81-18.13) p < 0.05
T 8.59 (-7.66-24.85) -5.44 (-15.49-4.59) p < 0.05
P -10.24 (-21.79-1.30) 1.49 (-5.14-8.14) p < 0.05
V10 QRS -4.27 (-53.94-45.39) -1.38 (-24.67-21.90) p < 0.05
T -3.70 (-15.75-8.35) -1.82 (-10.71-7.06) p < 0.05
P -4.42 (-16.11-7.27) 1.43 (-4.67-7.54) p < 0.05
V11 QRS -0.52 (-33.22-32.17) -3.03 (-20.74-14.68) p < 0.05
T -1.47 (-13.26-10.30) -0.47 (-8.25-7.31) p < 0.05
P -2.96 (-15.96-10.03) -2.68 (-3.97-7.28) p < 0.05
V12 QRS -1.12 (-28.82-26.56) -2.75 (-16.53-11.16) p < 0.05
T -4.09 (-15.88-7.69) -0.14 (-7.16-7.46) p < 0.05
TABLE III
THE RESIDUALS OF THE GLOBAL MODEL AND THE PARTIAL MODELS.
are narrower compared to the interquartile ranges of the global
model. The residuals of the global model and the residuals
from the partial models were not form the same underlying
distribution according to the Signed-Rank test.
An example of the improvement of the point estimation
is shown in fig. 8. The depicted segments are derived from
lead V 9. The upper row shows an example of using the
global model for estimating the three segments in lead V 9,
and the lower row shows an example of using the partial
models for estimating the same data points. The blue curve
indicates the measured signal and the red curve indicates the
estimated signal. The P segment appears to be poorly estimated
compared to the two other segments, however the resolution
of the vertical axis are not identically in the subplot of the
segments.
IV. DISCUSSION
Studies have proposed linear regression models for pre-
dicting the posterior ECG leads by means of the standard
leads. In our previous study [1], we presented a physiological
interpretation of the regression coefficients. We suggest that an
application of the model on AMI patients would yield poor
results according to the assessment based on the interpretation
of the regression coefficients. In this study, the aim was to
examine two different methods of modelling the regression
coefficients, and furthermore to improve the accuracy of the
point estimation of the posterior leads by modelling the ECG


























































Fig. 4. The results of the simple regression of the leads V 5 and V 7. In the
upper left subplot the output of leads V 5 and V 7 are given and the dashed
line indicates the regression model. In the three other subplots the segments
P, QRS and T are given, the solid line indicates the partial regression model.
A. Average model
The best median R2 performance of the average method was
obtained for the posterior lead V 7. The overall performance
of the average method compared to the pooled method was
poorer, according to the results of table II. By modelling
the posterior leads by the average method, we performed a
patient wise minimization of the error, and the final model
was an average of the individual models, while in the pooled


















































































































Fig. 6. An example of modelling the posterior leads by the average model.
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Fig. 7. The median residuals and the interquartile ranges of the three segments for leads V7-V12. The dashed lines indicate residuals from the global model





















































Fig. 8. An example of the segments P, QRS and T estimated by global model (upper row) and by the partial models (lower row) (leads V 9). The blue line
indicates the measured signal and the red line indicates the estimated signal.
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method the minimization of the error was performed on the
whole subject subset. In fig. 2, we see a large dispersion
of the individual regression coefficients for the independent
variables and this could be explained by the large number
of independent variables and noise. The standard leads are
highly correlated [1] and therefore the determination of the
regression coefficients are depended on random noise in the
standard leads.
As an attempt to limit the influence of the noise, we
reduced the number of independent variables from eight to
three. In the example shown in fig. 3, the posterior lead V 9
is modeled by two different models. Model: A) including
correlated independent variables and model B) including non-
correlated independent variables. The performance of model
A for V 9 is better than the average method with regard to
median R2 and the interquartile range, see table II. However,
we still observe a large dispersion of the regression coefficients
of leads V 5 and V 6 (second row, first column, fig. 3), while the
dispersion of the regression coefficients of lead V 1 is limited.
The correlation of lead V 5 and V 6 is almost equal 1, hence the
determination of the magnitude of the regression coefficients
of these two leads are still depended on contain of noise in
the leads. By substituting the lead V 5 with V 4, we obtain
a model with non-correlated independent variables (model
B). The dispersion of the regression coefficients of model
B is less than the dispersion of the regression coefficients
of model A. The performance of the two models A and B
are almost equal. The median R2 for model A equals 0.50
and the median R2 for model B equals 0.49. Our results
indicate that, choosing highly correlated independent variables
yield unstable regression models. We therefore believe that
a physiologically interpretation of a regression model with
highly correlated independent variables is complicated and it is
not reliable to assess the performance of the regression model
on AMI patients based on the interpretation of the regression
coefficients.
The pooled method is less sensitive for noise than the
average method, this is indicated by our results and we prefer
the pooled method in future studies. The average method
may be suitable in noise free recordings, but noise free ECG
recordings are practically not obtainable.
We also suggest a reduction of the number of independent
variables in the regression model for predicting the posterior
leads. However issues as; number of standard leads and which
standard leads, have to be considered. Theoretically, three
leads describing the x,y,z-directions in the torso are enough
to model the posterior leads, however which standard leads to
be chosen for the model is more complicated to decide. The
standard leads have to be highly correlated with the posterior
leads and at the same time they must not be highly inter-
correlated. The most obvious method to select the independent
variables is the best subset regression method; though this
method does not take in to account neither the direction of
standard leads in the torso nor their inter-correlation.
B. Global model vs. partial models
The global regression model is predominantly determined
on the data points of the QRS-complex; this is indicated by the
results of simple regression models of the standard lead and the
posterior lead, see fig. 4. This is explained by the property of
the least square estimator which minimizes the mean squared
error. The simple regression model is based on the entire ECG
signal (the independent variables is V 5 and the dependent
variable is V 7), and the model is depicted as a dashed line.
The partial simple regression models are based on the three
segments, depicted as solid lines. For the P and T segments,
the dashed line is not centred with respect to the centroids in
these subsets of data points. However, in the QRS segment,
the dashed line and the solid line are almost identical and are
centred with respect to the centroid. The different slopes of the
solid lines in fig. 4 are a consequence of unequal manifestation
of the three waves in the different leads. As an example, let
us first consider the P segment. In lead V 5 and in lead V 7
the P segments are almost equally manifested (see fig. 4 upper
right column) with respect to the magnitude, whereas the QRS
segment is obviously not equally manifested in both leads (see
fig. 4 lower left column). Therefore, partial models yield better
results with respect to point estimation. The general tendency
of the median residuals of the partial models is closer to zero
compared to the global model. Furthermore, the interquartile
ranges in the partial model are more narrow compared to
the global model, this indicates a reduction of the number
of extreme errors in the partial models compared to the global
model, see fig. 7.
To quantify the improvements of modelling the ECG in
partial models the residuals are used instead of coefficient of
determination R2. The R2 is a ratio of the error when using
the regression line and the error when not using the regression
line for estimation. If the error of using the regression line is
zero, then the R2 = 1. In cases where the error using the
regression line is greater than when not using the regression
line then R2 < 0, which is an invalid result. In some cases
in the global model this occurred, and to avoid this problem
of invalid results only the residual (or the error using the
regression line) were used to quantify the improvements.
C. Perspectives
With reference to the new knowledge achieved in this study,
it is not possible to reject the concept of using linear regression
models to predict the posterior leads V 7-V 12 on AMI patients.
In our previous study, we expected the linear regression model
to be invalid in AMI patients as a consequence of relative
small regression coefficients for specific leads. A physiological
interpretation of the regression coefficients is complicated;
this was acknowledged in the study. Hence assessing the
performance of the regression model in AMI patients is
not reliable. The method of pooled data to determine the
regression coefficients was less sensitive to noise compared
to the average method and therefore this method is preferable
in future studies. Furthermore, a reduction of the number of
highly correlated independent variables may yield stable and
physiological interpretable regression model. To confirm the
validity of linear regression models to predict the posterior
leads on AMI patients, studies containing ECG recordings
during ischemic periods must be conducted.
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By segmentation of the ECG signal and performing par-
tial linear regression models, we obtained improvements in
the point estimation compared to the global model. Several
studies have investigated the issue of minimal lead sets for
reconstruction of the standard 12-lead ECG [4]. They are
all conducted on the entire ECG signal and have obtained
acceptable accuracy with reduced leads sets. Global linear
regression models are mainly based on the data points of the
QRS-complex, and therefore a poor estimation of the P- and
T-waves was indicated by our results. This may question the
accuracy of the estimated leads from the reduced lead sets.
In conclusion, the method of pooled data was less noise
sensitive compared to the average method. Modelling the ECG
in segments yield an improvement of the point estimation
compared to the global regression model. With reference to
our results it is not possible to reject the concept of using
linear regression models to predict the posterior leads V 7-V 12
on AMI patients.
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Chapter 1
Introduction
This report is documentation of the solution within the problem of making an
algorithm to detect ST-elevation myocardial infarction and Non-ST-elevation
myocardial infarction. The project is carried out as a cooperation between
Department of Health Science and Technology, Aalborg University and De-
partment of Cardiology, Skejby Hospital.
The ﬁrst ﬁve chapters are description of the diﬀerent scientiﬁc ﬁelds con-
cerning with the automatic diagnosis of acute myocardial infarction (AMI).
Chapter six is concerning with statement of the problem.
For experienced readers in the ﬁeld of ECG and AMI, the ﬁrst ﬁve chapters
are trivial, but for those who are not conﬁdent with these ﬁelds these chap-
ters may be informative.
The chapters seven and eight are the documentation of the algorithm. And





Acute coronary syndromes is a general deﬁnition of several lethal conditions
of the heart, and includes: unstable angina pectoris, ST-elevation myocardial
infarction and non-ST-elevation myocardial infarction (ICD10 120-125) [1].
A medical deﬁnition of Acute Myocardial Infarction (AMI) is sudden onset
of myocardial necrosis due to the formation of a thrombosis in the coronary
arterial system obstructing arterial blood ﬂow to the cardiac muscle [2].
The World Health Organization (WHO) estimates approximately 30 % of
all deaths in 2004 were caused by cardiovascular disease corresponding to
7.2 million people worldwide. This makes cardiovascular disease as the most
leading death cause in the world. [3]
The incidence rates of AMI in USA is reported to be approximately 40-50
cases per 10,000 persons [4, 5]. In Europe, there are diﬀerences between the
countries in the northern and the southern part of Europe. In the countries
in the north the incidence rates are similar those in USA, while in countries
in the southern part show lower incidence rates [68].
About 10 %-15 % of the incident cases of AMI die of disease in the north
Europe [911]. In this per-cent interval also non-hospitalized cases of AMI
are included. The hospitalized mortality rates are lower, due improved ther-
apeutical and operational techniques.
There no clear consensus about the sex diﬀerences in mortality rates. Ac-
cording to WHO there are no distinct diﬀerences in deaths caused by is-
chemic heart disease among males and females [3], while some studies re-
ports higher rates for women [8] and others reports lower mortality rates for
females [12,13].
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2.1 Temporal changes in incidence and mortality of
AMI
WHO conducted a study to clarify the temporal chances in cardiovascular
disease in the period of 1979-2002. A total population of approximately
10 million peoples in 21 countries, makes this study to the largest study
of temporal changes in incidence and mortality of AMI conducted yet [14].
The report by WHO and others conclude the incidence and mortality rates
have been decreasing over the last decades [9, 14, 15]. The factors that may
have the most impact on the decreasing incidence rates are improvements
in life-style related factors such as food habits, smoking, physical activity
etc. They also conclude the declining case-fatality rates are the main cause
of the decreasing mortality rates. Declining case-fatality rates are due to
improvements in medical interventions [9, 1517]
Similar tendencies in decreasing incidence and mortality rates have been
reported in Denmark in the period of 1985-2000 [18,19]
2.2 The economical burden of AMI
The economical cost of diagnosis, treatment and rehabilitation of AMI,
amounts to a signiﬁcant portion of the total budget of the health care ex-
penses. In Denmark expenses of AMI is in the range of 6.3 % - 7.5 % of
the total health care expenses in the ﬁve regions [20]. In UK the expenses
associated with AMI amounts to ¿7,06 billion, where the expenses for the
disease, informal care and productivity loss were incorporated in the calcu-
lations [21]. AMI is the disease with the highest economical burden, in the
UK [21].
Taylor et al. estimated the amount of the diﬀerent economical issues (e.g.
medication, operation etc.) in the treatment of a AMI [22]. They found the
ward expenses account for more than 50 % of the total amount per patient
in treatment [22]. They also found that countries with higher expenditure
on patients tended to have lower case-fatality rates [22]. Despite the high
economical expenses in treatment of AMI, the fact of the decreasing inci-




In this chapter there will be an short introduction to the anatomy of the
heart. The action potential initiated in cardiac cells diﬀer form the action
potential in the muscle cells, a brief description on cellular level will be
provided. Likewise the electrical conducting system of the heart which is
the underlying cause of the electrical potentials measured by ECG will be
introduced. Finally the etiology of AMI will be described.
3.1 Anatomy and the function of the heart
The heart is the organ that provides blood supply to the rest of the body.
The heart is a muscle and therefore it consumes oxygen and produce waste
products during the work.
The heart consist of four chambers see ﬁgure 3.1. The heart can be divided
in to two parts; the right and the left part for convenience. In each part
there is an atrium and a ventricle, which is separated by atrio-ventricular
valves tricuspid valve (in the right part) and the mitral valve (in the left
part). The right ventricle (RV) is connected to lungs by pulmonary artery
and the left ventricle (LV) is connected to main arteries by aorta. [24]
In the right atrium the venous blood from superior and inferior vena cava
is gathered and transported to the right ventricle during the diastole when
the tricuspid valve opens. During the systole the heart squeezes the blood
from the right ventricle through the pulmonary artery to lungs for the decar-
bondioxygenation and oxygenation processes. The oxygenated blood from
the lungs enters the left atrium by pulmonary veins and is transported to
left ventricle during the diastole when the mitral valve opens. During the
systole the left ventricle squeezes the blood through aorta for distribution to
the tissue. [24,25]
The walls of the heart consist of cardiac muscle cells, and these cells have
diﬀerent properties than skeletal muscle cells e.g. duration, initiation etc.
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Figure 3.1: Cross-sectional (frontal) view of the heart. [26]
The muscle walls are oriented spirally and is divided into four groups, see
ﬁgure 3.2. Two groups (top row) cover both ventricles on the outside and one
group covers both ventricles (beneath) and ﬁnally the fourth group covers
only the left ventricle (bottom row). [26]
Figure 3.2: Orientation of cardiac muscle ﬁbers. [26]
The blood supply to the heart is through three main arteries; right coronary
artery (RCA), left anterior descending artery (LAD) and circumﬂex artery
(LCX). Anatomically LAD and LCX are branches of left coronary artery
(LCA), see ﬁgure 3.3. RCA and LCA originate from the trunk of ascending
aorta. RCA supplies the anteroinferior and the medial posterior wall of
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the heart. On ﬁgure 3.3 the posterior arteries are illustrated with white
dotted borders. The LAD supplies the lateral anterior wall of the heart. The
LCX supplies the lateral and lateroposterior wall of the heart. RCA, LAD
and LCX are further branched in smaller arteries. The arteries innervate
the cardiac muscle wall from the epicardium to the endocardium. In case
of insuﬃcient blood supply to the arteries, the will be a positive pressure
gradient from the endocardium to the epicardium. As a consequence of the
innervation direction the ischaemia commences as subendocardial and can
in severe case develop as transmural ischemia.
Figure 3.3: The arteries of the heart. The arteries on the posterior wall of the heart
are illustrated with white dotted borders.
3.2 The electrical conduction system of the heart
In the right atrium a group of specialized cells called sinus node are placed.
They are self-excitatory and generate the action potential (heart beat fre-
quency). From sinus node the action potential propagates to the atrioventric-
ular node and the bundle of His. From this point the signal pathway divides
into two branches termed bundle of branches. The bundle of branches in-
nervates both ventricles and ends in the purkinje ﬁbers, see ﬁgure 3.4. The
frequency of the heart is not only depended on the sinus node, but other re-
gions in the heart are also self-excitatory and can generate action potential to
keep the heart pumping, in case of malfunction of sinus node [25]. On ﬁgure
3.4 the diﬀerent regions in the heart, where the cells are self-excitatory are
marked with an arrow, and their self-excitatory frequency is given in beats
per minute.
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Figure 3.4: The electrical conduction pathway in the heart. The self-excitatory regions
in the heart are marked with an arrow, and the self-excitatory frequency is given in beats
per minute. [26]
3.3 The action potential in cardiac muscle cells
The action potential in a cardiac cell diﬀer form a skeletal muscle cell in
duration of the potential. The action potential in skeletal muscle is a short
burst with a duration of few milliseconds (msec) [27], while the cardiac action
potential has a duration of approximately 250 msec [24].
The cardiac action potential can be grouped in three phases; depolarization,
plateau and repolarization, see ﬁgure 3.5.
Depolarization
The depolarization phase occur when the transmembrane potential (Vm)
rises to -60 mV . When the Vm reach the threshold the membrane becomes
permeable to Na+. The result is rapid increase in the Vm to approximately
+30 mV .
Plateau
At a Vm of +30 mV the Na+-channels close, and the cell now actively
transport the Na+ out, meanwhile Ca2+-channels open. As a consequence
of the opposite transport the Vm remains about 0 mV for approximately 175
msec.
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Repolarization
At the end of the plateau phase Ca2+-channels close and K+-channels open
(eux), and cause a decrease in the Vm to resting potential.
In skeletal muscles the action potential is initiated by motor nerves, while
in cardiac muscles the action potentials are produced by it own (pacemaker
cells) [25].
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Figure 3.5: Action potential in cardiac muscle cell. The action potential is grouped in
three phases; depolarization, plateau and repolarization. For further description of the
phases see the section above.
In chapter 4 the link between the action potential in cardiac muscle cells
and the recorded signal of the ECG will be clariﬁed. This is an interesting
concept to understand the origin of ECG.
3.4 Etiology of myocardial infarction
A medical deﬁnition of AMI is sudden onset of myocardial necrosis due to
the formation of a thrombus in the coronary arterial system obstructing ar-
terial blood ﬂow to the cardiac muscle [2].
The underlaying causes of AMI can be grouped as; unstable angina (UA),
non-ST-segment elevation AMI (non-STEMI) and ST-segment elevation AMI
(STEMI). These three gruops refer to the clinical ﬁndings. UA is a result
of reduced perfusion to the myocardium due to a non-occlusive thrombus,
and no biochemical markers of necrosis are found. non-STEMI is a clinical
condition similar to UA, however biochemical markers of myonecrosis are
found and no elevation of the ST-segment of ECG occur. STEMI is the
most lethal condition, and is secondary to a total occlusive thrombus in the
coronary artery. [28,29]
The formation of thrombus is caused by fatty deposit in the wall of coronary
arteries [24]. The fatty deposit grows as cholesterol cults together in the
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wall, and can narrow the passage and reduce the blood ﬂow through the
artery. In severe cases spasms in the artery walls can further reduce or stop
the blood ﬂow to the innervated regions of cardiac wall. This will immediate
cause oxygen lack in the cell and can induce ischemia. Within 60 sec, loss of
the myocardial contractility occurs, and within 20-40 min of total occlusion
the loss of viability occurs. [24, 25,30]
A narrowing of a coronary artery do not necessarily induce ischaemia, at
resting or moderate work. While the cardiac oxygen demand rise e.g. when
exercising, and the the blood supply is insuﬃcient ischemia in the cardiac
cells will be induced and can have fatal outcome [25].
Figure 3.6: Anterior view of the heart. Left; cross-sectional view of an arteriosclerotic
LAD
In ischemic tissue the electrical impulses are conduct slower than in well
perfused tissue. The disturbance in the electrical pathway is reﬂected in the




This chapter contains mainly medical related issues as; how to clarify the
physical symptoms of the patient, and how to support the subjective state-
ments with objective investigation methods and ﬁnally the treatments avail-
able at present.
4.1 Physical symptoms of AMI
The most evident sign of AMI is chest pain (angina pectoris). Often the
origin of the pain is retrosternal, and is described by patients as tightness,
squeezing or burning sensation in the chest region. The pain can radiate to
left/right arm, ulnar, throat, neck, jaw and teeth. The intensity of pain vary
between patients from mild discomfort to unbearable pain in the chest area.
Some patients also report dyspnea. All these symptoms are not signiﬁcant
for AMI, and can be caused by e.g. extra cardiac conditions. Therefore the
clinical ﬁndings must be supported by supplementary objective investigation
methods. [31]
4.2 Diagnosis of AMI
UA, non-STEMI and STEMI have the same underlying physical condition,
but are deﬁnitions of the severity of the physical condition. Therefore the
diagnosis procedure is almost the same for all three conditions, and will be
described as one diagnosis procedure. The complete diagnosis procedure








As diagnosing any other diseased condition the history of the patient is
important, and may exclude unnecessary diagnosis and encourage a rapid
and adequate treatment. The history can provide useful information about
drug intake, exercise level, smoking and life-style, which are all of importance
for the physician to make a correct diagnosis.
ECG
In all patients complaining of angina pectoris an ECG will be performed.
The ECG presents useful information for the physician about the electrical
conductivity of the heart. In UA and non-STEMI patients a ST-segment
depression during chest pain is a clinical ﬁnding for ischemia, but not a
signiﬁcant ﬁnding. If the ST-segment depression is presented in ECG during
chest pain and in pain free periods, the diagnostic value of the ﬁndings are
less speciﬁc. Often inverted T-wave occurs in the ECG of patients with
UA or non-STEMI. ECG recorded during attack of chest pain have more
diagnostic value than ECG recorded in pain free periods. In STEMI patients
the frequent abnormality is elevation of the ST-segment, and subsequently
Q wave occurs and the T wave is inverted. The elevation of ST-segment will
return to the isoelectric line with time, usually within 48 hours. [29, 29,32]
The characteristics of ECG in patients with AMI will be further described
in chapter 5.
Biochemical markers
Necrotic myocardial secrete macromolecules and enzymes and these sub-
stance are measurable in the blood [33]. Release of creatine kinase (CK) in
the blood was proposed as marker of myocardial necrosis and it has been
standard in emergency departments since 1980's [33, 34]. The disadvantage
of CK as marker is the CK release into the plasma do only occur in case of
lost viability [35]. However the introduction of troponin T and I, has over-
come this problem and now it is possible to detect necrosis before the state
of viability [29,36].
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Imaging
Imaging modalities are primarily not used as diagnostic tools to determine
the presence of AMI. When the diagnosis of AMI is manifested then the
imaging modalities are used to determine the location of the AMI and the
severity. Modalities with advantages in the ﬁeld of imaging the coronary ar-
teries can be echocardiography, MRI, CT and coronary angiography (CAG).
CAG is a technique, where the coronary arteries are illuminated by an imag-
ing agent and the investigation of the arteries are supervised by x-ray, see
ﬁgure 4.1. This is often used, but in contrast to the other modalities men-
tioned this is invasive and is linked with a risk of complication.
Figure 4.1: X-ray of a chest anterior view. The occlusion is marked with a white arrow
4.3 Treatment of AMI
Treatment of AMI can be therapeutical or operational or a combination of
both. The aim of the treatment is to reduce symptoms, prevent future events
of AMI and reestablishment of baseline hemodynamic parameters. [29,33]
Less severe case of AMI is often controlled therapeutical. The therapeutical
agents consist of three main groups; vasodilators, antiplatelet and anticoag-
ulant. [29, 33]
The main eﬀects of vasodilators are to reduce the oxygen demand of the
heart and simultaneous increase the oxygen delivery to the heart. Agents in
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this category is e.g. nitroglycerin and beta-adrenergic blockers. Antiplatelet
are a group of agents to prevent thrombus formation in the blood. An-
tiplatelet are eﬀective in artery circulation, while anticoagulant have the
same antithrombotic eﬀects as antiplatelet, but are most eﬀective in venous
circulation. Example of an agent in the antiplatelet group is aspirin, and an
agent in the anticoagulant group is heparin. [29,33,37]
The aim of the operational procedures is to restore the blood supply to the
ischemic areas of the heart. The mainly used methods are percutaneous
transluminal coronary angioplasty (PTCA) or coronary artery bypass graft-
ing (CABG). The PTCA is the method connect with less post-operational
complications. A catheter is inserted in to one of the main arteries in body,
and lead to the coronary artery of concern, see ﬁgure 4.2 left column. A
balloon is inserted in the occluded area and inﬂated to restore normal ﬂow
across the occlusion, ﬁgure 4.2 middle column. During the withdrawal of the
catheter a stent is placed in the dilated area to keep it open, ﬁgure 4.2 right
column. [29,33,38]
Figure 4.2: An illustration of the PTCA step by step.
The CABG method is more advanced and requires an surgical opening of
the thorax. The blood ﬂow through the total occluded area is bypassed
with inserting an auto graft artery, often the mammary artery, see ﬁgure
4.3. [29,33,39]
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Figure 4.3: An illustration of the concept of CABG
Chapter 5
Electrocardiogram
The chapter is an overview of the basic technical concept of electrocardio-
gram (ECG). First section will contain short introduction to what the ECG
is, how to obtain it and the 12 leads. A section will investigate the gene-
sis of ECG, from intracellular action potentials to the electrical potentials
measured on the precordium. Finally there will be a brief description of
transformation of ECG (temporal information) data to vectorcardiography
(VCG, spatial information).
5.1 The basics of ECG
In chapter 2 we dealt with the cardiac muscle contraction on cellular level.
Every contraction of a cardiac muscle is associated with a depolarization of
cardiac muscle cell. All these "individual" contraction can be measured as
an electrical potential on the precordium by means of electrodes. [32]
The morphology of the ECG is illustrated in ﬁgure 5.1. The peaks and
bottoms on the ECG are designated with the letters P, Q, R, S and T, and
refer to diﬀerent physiological events in the heart. The P wave corresponds
to the depolarization of the cells in the atria. The complex QRS is the
depolarization of the ventricles, and the amplitude of the QRS waves is
larger than P wave due the larger mass of muscle in the ventricles. The T






Figure 5.1: The morphology of an ECG.
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The ECG is recorded by means of electrodes placed on the limbs and the
precordium. The standard 12-lead ECG have three electrodes placed on the
limbs (right arm, left arm and left leg), and six electrodes placed on the
precordium, as shown in ﬁgure 5.2.
Figure 5.2: The placement of the electrodes V1-V6 on precordium.
By means of the nine electrodes 12 derivatives of the heart can be obtained.
Six of the 12 derivatives depict the heart on the vertical plane, and the others
depict the heart on the horizontal plane. The intra diﬀerences between the
derivatives in the two planes are the angle where the electrical activity of the
heart is depicted. On ﬁgure 5.3 the diﬀerent planes and angles the derivatives












Figure 5.3: A schematic illustration of the 12 derivatives of the electrical activity of the
heart.
5. Electrocardiogram 5.1. The basics of ECG
To understand how it is possible to "look" on the heart from diﬀerent angles,
it is necessary to understand the fundamentals of electrode. Figure 5.4 shows
the properties of the bioelectrical potential measured by means of electrodes.
If the electrical resultant vector is perpendicular and toward the electrode,
the amplitude will be positive and maximum (in order to calibration). If
the electrical resultant vector is perpendicular but heading away from the
electrode, the amplitude will be maximum but negative. In case of an oblique
angle the amplitude will be lesser than in the cases of perpendicular angles.
The ﬁnal case is a parallel electrical resultant vector, which will cause no







Figure 5.4: A schematic illustration of the angle of the electrical resultant vector. A
perpendicular resultant vector will result in a maximum eﬀect, and a parallel vector will
not have any eﬀect.
As described in chapter 2 the contraction of the heart starts in the atria
and moves lateroinferior. The electrical resultant vector in the horizontal
and vertical plane moves counter clockwise in an ellipse orbit, see ﬁgure 5.5.
The ﬁgure illustrates the heart viewed in two diﬀerent planes; horizontal and
vertical, respectively. The green orbits indicate the location of the electrical
resultant vector in diﬀerent time instance. Actually there are two orbit; a
big and and a small one indicating depolarization of atria and the ventricles.
Further, which parts of the heart the diﬀerent electrodes look on are also
depicted as dotted arrows. By means of placing the electrodes in diﬀerent
positions it is possible to record the electrical resultant vector around the
ellipse orbit. The leads I, II and VL look at the left lateral surface of the
heart, III and VF look at the inferior surface, and VR looks at the right
atrium. The precordial leads V1- and V2 look at the right ventricle, V3
and V4 look at the ventricular septum and the anterior wall of the left
ventricle, and V5 and V6 look at the anterior and lateral walls of the left











Figure 5.5: A horizontal and vertical view of the heart.
5.2 Origin of ECG
Chapter 2 provided a description of the generation of action potentials in
cardiac muscle cells. In this section the link between the action potential
and the potential measured at the precordium (or ECG) will be described.
The description of the origin of ECG is a simpliﬁed model with to impor-
tant assumptions. The ﬁrst, the cardiac muscle cells are connected by low-
resistance pathways. By means of this a cell can stimulate the following cell.
The second, the action potential can only propagate in parallel direction to
the wave front. [26,41]
Depolarization
A highly simpliﬁed model of the cardiac muscle cells is provided in ﬁgure 5.6
A and D. The cells are aligned parallel and the wave front is perpendicular
to the direction of the cells. On left part of the model of the muscle the cells
are in resting phase (they are not stimulated yet), on the right part of the
model the cells are activated (they are stimulated). In the middle part of
the model the wave front appears. In the vertical box the main mechanism
causing the depolarization (inﬂux of Na+) or the repolarization (eux of
K+) are depicted. On the outer-left side a measuring electrode is attached,
and on the outer-right side a reference electrode is attached. The ECG is
measured as the potential diﬀerence between these electrodes.
When the Vm reach -60 mV the inﬂux of Na+ begins and the Vm reach +30
mV rapidly, see ﬁgure 5.6 B. While the extracellular potential (Po) decrease
from 20 mV to -40 mV as a cause of decrease in the amount of Na+ in extra
cellular plasma. When the wave front is propagating from right to left, the
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left side will be predominantly positive (resting phase), and the right side
will be predominantly negative (activated phase). As the ECG is measuring
the extra cellular potential diﬀerence a positive signal will appear, ﬁgure 5.6
C. [26,41]
Repolarization
The repolarization is diﬀerent form the depolarization, in two main points.
The depolarization is a wave front where previous cell stimulates the next
cell. The repolarization occur after a time instant, because the depolarization
only appears in certain time interval. Therefore the repolarization is not
stimulated by surrounding cell, but a cause of a intrinsic mechanism in the
cell. As a consequence of this the cells that are depolarized ﬁrst will also
repolarize ﬁrst. The duration of the repolarization is 100 ms (denoted DZ,
depolarization zone or RZ, repolarization zone), while the depolarization
only last 1 ms.
During the repolarization the situation in our muscle model is; on the left
side the cells are activated (they are still stimulated), on the right side the
cells are in resting phase (they are already repolarized), see ﬁgure 5.6 D. The
eux of K+ will cause an decrease in Vm, form 30 mV to -80 mV . Opposite
the Po will increase, as a consequence of the increased amount of K+ ions in
the extra cellular plasma, ﬁgure 5.6 E. Therefore the left side of the model
is predominantly negative and the right side is predominantly positive. As
the electrical resultant vector is pointing away from the measuring electrode
(in this idealized case also perpendicular on the electrode) a negative ECG
signal will appear. [26,41]
5.3 Converting ECG data to vectorcardiography
Vectorcardiography (VCG) is a technique used rarely in clinical situations. In
1970's the novel technique was popular and foretold a huge clinical impact,
but the VCG has never gain a footing in clinic. The VCG is said to be
superior to ECG in e.g. to detect ischemia.
As aforementioned VCG is depiction of the electrical ﬁeld produced by the
heart during a heart cycle. When consider a VCG we assume the heart as a
point generator of electromotive forces, and the body (thorax) as a volume
conductor. For every time instance the point generator (heart) produce a
vector, with a magnitude corresponding to the strength of the electromotive
forces and a direction of the force. By joining all these instantaneous vectors,
we obtain a VCG. [41,42]
VCG can be recorded by means of vectorcardiograph, but it is also possible
to convert ECG to VCG by a transformation matrix. The transformation is
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Figure 5.6: A schematic illustration of the origin of ECG. Left column shows the
depolarization phase and the right column shows the repolarization phase. The three rows
show; the model of the cardiac cells, the changes in the extra cellular potential (Po) and
the transmembrane potential (Vm) and the ECG recorded by means of electrodes,
respectively. Notice the time axes are not comparable. Simpliﬁed by inspiration of [26].
given by:












where the left side is the three dimensional coordinates of the VCG. The
matrix on the right side contains the ECG leads. The matrix TID is e.g.
Inverse Dower transformation matrix [43], which contains data yielding the
linear transformation of the ECG data from temporal to spatial information.
By plotting the x, y, z-coordinates in the space yields a VCG as shown
in ﬁgure 5.7. [41, 42] The VCG consist of three loops (ellipses); QRS, P
and T respectively. The main axis of the ellipses are directed toward the
largest amount of muscle (left ventricle). The largest loop is the ORS-loop
corresponding to the depolarization of the left ventricle.




Figure 5.7: Normal VCG in horizontal and vertical plane.
Chapter 6
ECG as a tool for diagnosis
In this chapter the aim is to investigate the options of ECG in clinical prac-
tice. The last chapter was technically, this chapter is more clinically. The
ﬁrst section is how a AMI look like on an ECG. And how it is possible to lo-
cate the area of occlusion by analysis of an ECG. Several studies has showed
an early diagnosis of AMI has a positive impact on the outcome. The last
section of this chapter is a review of the present literature on this issue.
6.1 The ECG in AMI
As aforementioned the RCA supplies the right ventricle, LAD supplies the
anterior, lateral, septal and inferoapical parts of the left ventricle. LCX sup-
plies the posterior, lateral and inferior parts of the left ventricle. Occlusions
in RCA and LAD appear in the ECG as ST-elevation in the diﬀerent leads,
according to the location of the thrombosis. Occlusions in LCX are often
diﬃcult to ﬁnd in standard 12-lead ECG, because they often appear without
ST-elevation in the ECG. [44]
Anterior wall infarction
Typically an occlusion in the anterior wall will cause ST-elevation in the
precordial leads V2, V3 and V4. However elevation in other leads occur, in
accordance with the speciﬁc branch of LAD where the occlusion is. [44]
Proximal occlusion of LAD, see ﬁgure 6.1 arrow 1, will hinder perfusion of
the diagonal and 1. septal branch and cause ischemia in left ventricle and
the septal wall. In the vertical plane ST-elevation occur in I, VR and VL,
and ST-depression in VF . In horizontal plane ST-elevation in V1, V2 and V3,
and ST-depression in V5 and V6.
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Figure 6.1: frontal view of the heart. The coronary arteries; RCA, LAD and LCX and
their main branches are depicted. The numbers indicate diﬀerent locations of occlusion
in LAD.
Distal occlusion of LAD, see ﬁgure 6.1 arrow 4, will obstruct perfusion to the
inferoapical area and induce ischemia. In the vertical plane ST-depression is
seen in VR, and in the horizontal plane ST-elevation is seen in V2-V5. [44]
The last two cases described is an inter-patient diﬀerence of ramiﬁcation
of the 1. septal branch. The ramiﬁcation of septal branch can either be
proximal or distal to the diagonal branch, see ﬁgure 6.1 arrow 2 and 3. [44]
If the 1. septal branch is located distal to the diagonal branch, and an
occlusion occur intermediate of these branch (arrow 3 in ﬁgure 6.1), ischemia
in the septal-apical area will be induced. In the vertical plane ST-depression
in lead VL, and in the horizontal plane ST-elevation is in the leads V1-V4. [44]
In patients where the 1. septal branch is located proximal to the diagonal
branch (arrow 2 in ﬁgure 6.1), an intermediate occlusion will induce ischemia
in the inferoapical area. In the vertical plane ST-depression in leads III and
VR. In the horizontal plane ST-elevation in leads V2-V6. [44]
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Inferoposterior wall infarction
Occlusion in the RCA results in inferoseptal ischemia, and are reﬂected as
elevations in the vertical plane in leads II and III. Since the ST-segment
vector is directed toward lead III, the elevation is more pronounced in lead
III than lead II, and also causing ST-depression in lead I and VL. [44]
Occlusions in LCX, cause ischemia in posterolateral area, and the ST-segment
vector is pointing toward lead II. The ST-elevation is therefore more pro-
nounced in lead II than lead III, but often occlusions in LCX do not show
any ST-elevation on ECG.
All the diﬀerent patterns in ST-elevation/depression in diﬀerent location of
the occlusions in vertical and horizontal planes are summarized in table 6.1
for convenience. [44]
Anterior wall Inferoposterior wall
Prox.(1) Dis.(4) Sep.(3) Sep.(2) RCA LCX
I ↑ ↓
II ↑ ↑ II>III
III ↓ ↑ III>II ↑
VR ↑ ↓ ↓
VL ↑ ↓ ↓ VL>I
VF ↓ ↑
V1 ↑ ↑
V2 ↑ ↑ ↑ ↑
V3 ↑ ↑ ↑ ↑ ↓
V4 ↑ ↑ ↑ ↓
V5 ↓ ↑ ↑
V6 ↓ ↑
6.2 The impact of early diagnosis of AMI
Early diagnosis of AMI is recommended by the American Heart Association
and others [4547]. The recommendation is based on several studies investi-
gating the impact of early diagnosis of AMI on the outcome of the treatment.
To encourage early diagnosis, pre-hospital ECG components are often used.
These are integrated in existing devices in ambulance e.g. deﬁbrillators.
The ECG is acquired on the spot with least possible delay, and provides
an strong diagnostic tool. The ECG can be interpreted by special trained
paramedic [48,49] or transmitted by electronic communication line to a car-
diologist for analysis [50]. During the transportation to the hospital, the
cardiologist can decide a proper treatment or require further investigation of
the patient to comply with the most suitable treatment. The pre-hospital
ECG has shown equal precision as ECG obtained in hospital [5153].
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An work group in the National Heart Attack Alert Program recommended,
benchmarks on the treatment of AMI from the onset of symptoms to initial
treatment of the patient. They recommended reperfusion treatment within
60 min of symptoms onset or within 30 min of the arrival at hospital. [54]
These benchmarks are based on studies investigating the impact of early di-
agnosis of AMI for the outcome of the treatment. The studies had reported
an early diagnosis of AMI improved the outcome of the treatment [5560].
The results of Boersma et. al showed the mortality rates can be lowered
with 6.5 % if the reperfusion is initiated within the ﬁrst hour. By prolonging
the time to reperfusion increases the mortality rate and after 12 hours of
the symptom onset the reperfusion therapy is no longer eﬀective [58]. And
DeLuca showed the one-year mortality is increased by 7.5 % for each half an
hour of delay before initial treatment [59].
An eﬀective way of reducing the initial treatment time is by letting the
paramedics analyze the pre-hospital ECG on the spot, and decide the most
suitable hospital center for treatment. The so called door-to-balloon time
(entering hospital to PCI) was reduced form 112 min to 58 min by letting
the paramedics analyze the ECG [56]. The mortality rate was 0 % in MI
patients identiﬁed by paramedics and in the compared group of MI patients,
the mortality rate was 4.3 % [57].
Chapter 7
Discussion
7.1 Summary of analysis
Acute Myocardial Infarction (AMI) is sudden onset of myocardial necrosis
due to the formation of a thrombosis in the coronary arterial system, ob-
structing arterial blood ﬂow to the cardiac muscle [2].
The incidence rates of AMI in USA is reported to be approximately 40-50
cases per 10,000 persons [4,5] and in northern Europe similar rates have been
reported [8].
The economical cost of diagnosis, treatment and rehabilitation of AMI,
amounts to a signiﬁcant portion of the total budget of the health care ex-
penses. In Denmark expenses of AMI is in the range of 6.3 % - 7.5 % of the
total health care expenses in the ﬁve regions [20].
The ECG is a strong diagnostic tool and presents useful information for the
physician about the electrical conductivity of the heart. An occlusion of one
of the coronary arteries is reﬂected in an ECG, as an elevation of the iso-
electric ST-segment. In order to the location of the occlusion, ST-elevation
will appear in diﬀerent leads on the ECG.
Early diagnosis of AMI is recommended by the American Heart Association
and others [4547], and is based on several studies. Boersma et. al showed
the mortality rates can be lowered with 6.5 % if the reperfusion is initiated
within the ﬁrst hour [58], and DeLuca showed the one-year mortality is in-
creased by 7.5 % for each half an hour of delay before initial treatment [59].
The main hindrance of an early diagnosis of AMI is the presence of a spe-
cialist to correct interpret the ECG in the initial state of symptom onset.
Therefore are algorithms to automatic detect AMI in an early state been
developed.
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7.2 Review of previous work on automatic detec-
tion algorithm for AMI
Several study groups have dealt with automatic detection algorithm for AMI,
with varying success. Some groups are succeed with commercializing there
algorithm, but without widely acceptance in the clinical practice. This re-
view includes some of the main publication, and the purpose with the review
is to identify the limitation of the previous studies in this ﬁeld.
The previous work in the ﬁeld of automatic detection of AMI can be roughly
sub-divided in three groups:
Decision support Decision support system relying on quantitative and
qualitative parameters.
Body surface mapping Mapping the electrical potentials on the surface,
in high resolution.
Morphology Systems based on ECG morphology analysis.
Decision support
The algorithms in this group are mainly based on neural network, probabil-
ity models or regression models [6164].
Xue et al. developed a neural network model, where the input parameters
were diﬀerent features of the ECG and VCG and qualitative parameters as
age and gender. They compared the emergency physicians ability to diagnose
AMI correct with the assistance of the system and without the assistance of
the system. With the assistance of the system the emergency physicians im-
proved their sensitivity by 50 %. [61] Other decision support systems rely on
parameters such as biochemical markers, and qualitative parameters as age
gender and symptoms. The strength of decision support systems are they
include both quantitative and qualitative parameters, which is may assumed
to be non-correlated. The main limitation of these systems is the number
of input parameter and the easiness of obtaining the parameters. E.g. some
of the systems include biochemical markers [6264], and the determination
of the concentration of diﬀerent biochemical markers in the blood is only
possible after the arrival to the hospital. The critical time interval from the
symptom onset is therefore wasted on transportation only, without attempt-
ing to diagnose the AMI.
Body surface mapping
Body surface mapping (BSM) is a technique where the standard 12-lead
ECG is replaced with a electrode grid with e.g. 80 electrodes or more. By
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applying an electrode grid on the thorax (anterior) and on the back (poste-
rior) high resolution mapping of the surface electrical potentials is possible.
Owens et al. developed a algorithm based on BSM [65]. The input param-
eters in their model were features derived for the BSM. The performance
of their model was compared with the performance of the physician. The
sensitivity/speciﬁcity for the physicians were 60 %/ 99 %, respectively and
the sensitivity/speciﬁcity for the algorithm 77 % / 99 %, respectively. By
letting the physicians make the diagnosis supported by the developed algo-
rithm, the sensitivity increased to 85 %, and they concluded the model is
suitable for diagnosing patients with non-diagnostic ECG in particular. [65]
The strength of the BSM is the advantages of the high resolution mapping
of the electrical potentials, and the concept is evaluated and found better in
diagnosing AMI [6568], than standard 12-lead ECG. However the limitation
of the concept of BSM is too cumbersome in clinical practice, and has never
gained acceptance [69].
ECG morphology analysis
ECG morphology analysis is based on the technical ﬁelds of signal processing
and pattern recognition.
Diﬀerent approaches to morphology analysis of ECG have been tested. One
study analyzed the temporal changes in ST-segment, to detect known peri-
ods of coronary occlusion. By means of sampling continuously ECG, they
deﬁned three time points to evaluate ST-segment changes in the ECG. With
at set up of simpliﬁed rules for the ST-segment changes they classiﬁed the
patients in three groups; occluded, indeterminate and patent. The perfor-
mance of their algorithm was very well, but they concluded that the selection
of the lead of interest was done manually, and the lead of interest varied over
the precordium with the artery occluded. [70, 71]
Similar study was set up by Fiol et al., however their aim was to diﬀerentiate
between occlusion in the RCA and LCX in contrary to [70,71]. Further Fiol
et al. made predeﬁnition of the leads of interest included in the morphology
analysis. The leads included were I, II, III, V1-V3 and aV F . They concluded
the performance of their algorithm yield a good sensitivity and speciﬁcity
but only for occlusion in RCA. [72]
Lehmann et al. conducted a more comprehensive study [73], where they ex-
tended the standard 12-lead ECG with the right precordial leads V3R-V6R
and the posterior leads V7-V9. In the statistical analysis of the ECG mor-
phology, ST-elevation/depression, presence of Q-wave, presence of positive
or negative T-wave and R-wave were taken into account. The true classi-
ﬁcation of occlusion in LAD, RCA and LCX was 84 %, 74 % and 71 %,
respectively. However they did only include patients with angiographically
conﬁrmed AMI in this study, and therefore were not able to test the speci-
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ﬁcity of the algorithm. Based on their own results and another study [74],
they concluded the detection of an occlusion in LAD was the least cumber-
some, and the diﬀerentiation was more complicated when RCA and LCX
were involved. An review of the literature on the issue of diﬀerentiating
between RCA and LCX reveal no consensus about the ECG morphology
parameters to include in the statistical calculations. No robust algorithm to
detect both inferior and posterior infarctions has yet been developed, and is
the main disadvantage of these studies [7579]. By means of the 12 standard
leads it is possible to automatic detect occlusion in LAD, but to diﬀeren-
tiate between occlusion in RCA and LCX several studies have proved the
necessity of posterior leads [76, 8086]. But the application of the posterior
leads in the clinical practice is cumbersome and have not gained acceptance,
therefore algorithms including measured posterior leads are not desired in
clinical practice. Therefore the most suitable solution will may be an algo-
rithm based on the standard 12-lead ECG, where the posterior leads can be
derived and analyzed for diﬀerentiating between occlusion in RCA and LCX.
7.3 Aim
The aim of the study is to develop an algorithm to automatic detection
of AMI, based on 12-lead ECG. The ﬁrst intermediate aim is to develop a
linear model to derive the posterior leads by means of the precordial leads.
The second intermediate aim is develop an algorithm based on the 12-lead
ECG and the derived posterior leads to automatic locate the presence or an
absence of an occlusion in LAD, RCA and LCX.
Chapter 8
Method
8.1 Mathematical consideration of transformation
matrix
The linear transformation of the standard leads to the posterior leads is only
possible if the heart is assumed as a dipole with a ﬁxed location and variable
orientation and magnitude. The surrounding tissue e.g. lungs, adipose tissue
and bone together is assumed as a inﬁnite homogenous conductor [87].
The recorded leads are a projection of the electrical resultant vector of the
heart on the lead vector formed by the location of the electrodes.
The electrical resultant vector of the heart is depicted as an yellow arrow, on
ﬁgure 8.10, top. The lead vectors are depicted as blue vectors in the frontal
plane, bottom. The projections on leads I, II and III are marked with red
arrows. In matrix convention the projection is given as
v = lTRe (8.1)
where v is the matrix containing the recorded potentials, l is the denotation
of the lead vectors and is constant. Re is the electrical resultant vector of
the heart and is time dependant.
X, Y, Z-transformation
The transformation of the standard 12-lead ECG to X, Y, Z-signal is used as
a control step before transforming 12-lead ECG to posterior leads, see ﬁgure
8.2.
The transformation of 12-lead ECG to X, Y, Z-signal is a reduction of re-
dundant data. The transformation is given by
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Figure 8.1: Schematic illustration of projection of the electrical resultant vector of the
heart on the lead vector I, II and III. [40]










Figure 8.2: The ﬁgure illustrates the steps of transformations. The standard leads can
be assumed as matrix with eight time dimensions. It is transformed in to a
3-dimensional space also termed X,Y,Z-signal. The X,Y,Z-signal is further transformed
(back) into two separate three time dimensions. This ﬁgure shows two ﬁnal time space,
while we chose to derive the posterior leads V 7-V 12 in two diﬀerent trials.
Vxyz = TinvVs (8.2)
where Vxyz containing the 3-dimensional coordinates of the vector loops
(3xn matrix). Tinv is the improved inverse transformation matrix, described
in [61] (3x8 matrix). And Vs is the matrix containing the eight measured
standard leads (8xn matrix).
In ischemic conditions the heart will not perform as homogeneous dipole
model, and this will cause disturbed vector loops.
Posterior-transformation
Since the Re is the underlying cause of the potentials measured on the sur-
face, determination of Re is required for deriving the posterior leads. By
means of three independent leads, it is possible to determine the magnitude
of Re for diﬀerent time instance. Given that the vector l is column vector
with three elements, Re is given by
Re = (LT )−1V (8.3)
where L = (lI , lII , lIII) and V = (vI , vII , vIII)T . In fact lead III is not
independent but derived from leads I andIII. For convenience in this section
we a assume III is independent. By substituting Re in equation 8.26 with
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equation 8.27
v = lT (LT )−1V (8.4)
m
v = aV (8.5)
In standard ECG only eight of the 12 leads are independent (I, II, V 1, . . .
V 6). Transforming this fact in to a in equation 8.29 yields
a = lT (LLT )−1L (8.6)
Determination of a can be performed by measuring the standard leads. How-
ever in our case we use the derived X, Y, Z-signal from equation 8.2. Trans-
forming formula 8.29 to a computational equation containing X, Y, Z-signal
yields
Vp = AVxyz (8.7)
where p and xyz refer to the derived posterior leads and X, Y, Z-signal,
respectively. The unknown A contains the coeﬃcients of transformation.
A = (VxyzVTxyz)
−1VTxyzVp (8.8)
Statement of the matrix dimension
We expect the dimension of the matrix A must be 3x3, because we have
three independent leads (X, Y, Z) and desire to determine three unknown
leads.
Let us assume that the Vxyz is of dimension nx3, where n is the number
of samples and the three coordinates i space. Vp is of dimension nx3, the
three posterior leads. VTxyz is 3xn. Therefore the dimension of statement in
parentheses (VTxyzVxyz)−1 is 3x8. Dimension of VTxyzVp is 3x3. Then the
dimension of the matrix A in equation 8.33 is 3x3 · 3x3 = 3x3.
The deviation of the model
The evaluation of the transformation matrix, was made by a comparison of
the measured posterior leads and the derived posterior leads. The diﬀerence
between the measured and derived is calculated for each sample, and then
averaged by the total number of samples. The average error of the derived
posterior leads is given by






(|V measuredi − V derivedi |) (8.9)
If Errorave = 0 then the model is ideal.
8.2 Computational considerations
When computing the regression model all the ECG's measured were merged
together in three matrices containing [I, II, V 1 . . . V 6], [V 7 . . . V 9] and [V 10 . . . V 12],
respectively. By merging the data we assumed all the data is recorded under
same surrounding conditions. The data is given in matrix notation
Vs =

I1,1 II1,1 V 11,1 . . . V 61,1
... . . . . . . . . . ...
I5,1 II5,1 V 15,1 . . . V 65,1
... . . . . . . . . . ...
I1,j II1,j V 11,j . . . V 61,j
... . . . . . . . . . ...




V 71,1 V 81,1 V 91,1
... . . . ...
V 75,1 V 85,1 V 95,1
... . . . ...
V 71,j V 81,j V 91,j
... . . . ...
V 75,j V 85,j V 95,j

where j denotes the total number of subjects included in the regression
model. The notation for the leads V10−12 are trivial and are not shown.
When merging data, edge distortion will appear, see ﬁgure ??.
But in our study this was not of concern, because we were only interested
in the correlation between a certain data point in the independent variable
and the corresponding data points in the dependant variables. The edge
distortion should be of concern if some spectral analysis of the merged signal
were performed.
8.3 Post-processing of the derived signal
The transformation described above is actually a reduction or compression
of the signal in the time domain. In frequency domain the signal is low-
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ECG recorded from two different subjects
ECG recordings from two different subjects merged together
Edge distortion
Figure 8.3: Edge distortion can appear when data is merged.
pass ﬁltered, and applicable information in the signal may be removed. To
restore the high frequency component we applied a frequency domain ﬁlter













Figure 8.4: The diﬀerence in the frequency components of the derived and measured
signal.
The derived signal has a sharper attenuation in the higher frequency band
then the measured signal, for schematic illustration see ﬁgure 8.4. Since we
assume the system as a linear time invariant system following relationship
exist
Y (x) = H(z)X(z) (8.10)
where the Y (z) is the fourier transform of the derived signal, X(z) is the
fourier transform of the measured signal and H(z) is the transfer function.
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By determining the transfer function and applying to the derived signal, we
were able to restore the high frequency components of the signal.
H(z) = Y (z)−1derivedX(z)measured (8.11)
X(z)restoredderived = H(z)
−1Y (z)derived (8.12)
8.4 Least square estimator
The linear transformation of the standard leads to the posterior leads is only
possible if the heart is assumed as a dipole with a ﬁxed location and variable
orientation and magnitude. The surrounding tissue e.g. lungs, adipose tissue
and bone together is assumed as a inﬁnite homogenous conductor [87].
The recorded leads are a projection of the electrical resultant vector of the
heart on the lead vector formed by the location of the electrodes.
Figure 8.5: Schematic illustration of projection of the electrical resultant vector of the
heart on the lead vector I, II and III. [40]
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The electrical resultant vector of the heart is depicted as an yellow arrow, on
ﬁgure 8.10, top. The lead vectors are depicted as blue vectors in the frontal
plane, bottom. The projections on leads I, II and III are marked with red
arrows. In matrix convention the projection is given as
xi = lTi re (8.13)
where xi is the vector containing the recorded potentials (i, refers to the lead
of interest), l is the denotation of the lead vector and is constant. re is the
electrical resultant vector of the heart and is time dependant.
Least square estimators
By the model showed in ﬁgure 8.6, the output Y (t) (the posterior leads) is









Figure 8.6: Schematic illustration of the concept of multiple linear regression. [Inspired
by the simplicity of Johannes J. Struijk' way of thinking ¨^ ]
The relationship can be expressed algebraic
Y (t) = BX(t) (8.14)
The coeﬃcients of B are estimated by minimizing the error between the















(Yp(t)−B0 +B1xp,1(t) +B2xp,2(t) . . .+B8xp,8(t))2 (8.16)
Where t denotes the time and (p,#) denotes the patient and the number
of lead. To minimize the SSE, the partial derivatives of equation 8.16 with

















xp,8(t)(Yp(t)−B0 +B1xp,1(t) +B2xp,2(t) . . .+B8xp,8(t))





































For convenience the equations 8.18 can be written in matrix notation. The
general linear relationship is given by
Y = BX (8.19)
When incorporating the time variable and the patient variable, the matrices
Y (single column matrix), B (single column matrix) will be three dimen-
sional matrices. While matrix X is a nine dimensional matrix. In ﬁgure
8.7 this concept is illustrated schematically. The axis represent the time
dimension, the patient dimension and the lead dimension. Notice the lead
dimension is a non-ﬁgurative axe. Actually it represents eight dimension on
one axe, unlike the time and patient dimension which represents only one
dimension on each axis.
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Figure 8.7: Illustration of the dimensions of the matrices.
The equations in 8.18 written in matrix notation
X′Y = X′XB (8.20)
Assuming that (X′X)−1 is invertible, then
B = (X′X)−1X′Y (8.21)
The expression in 8.21 is actually the same as an Wiener ﬁlter. The nomi-
nator is the cross-correlation of the signal X and Y and the denominator is
the auto-correlation of the signal X. [89]
Let us assume the formula 8.21, is presenting the way to determine the
coeﬃcient matrix Bp with respect to intra-patient variation. Then the de-
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8.5 Signiﬁcance test of independent variables
The question of adding independent variables to the regression model yields
more information to our model is important to reduce redundant or noise
in the model. To test the signiﬁcance of the added variable a F-test is con-
ducted.
The null hypothesis:
H0 : βa1 = βa2 . . . = βaP
And the alternative hypothesis:
H1 : At least one β 6= 0







The aim of this analysis was to investigate the regression coeﬃcients in a
segment wise regression of the median beat consisting of P-, QRS-, and T-
wave.
The analysis was divided into three parts; determination of the mean dura-
tion of P-, QRS-, and T-waves, segmentation of ECG and ﬁnally calculation
of the regression coeﬃcients.
Segment duration
The segmentation of ECG did not require exact segmentation of the waves,
but the most important issue was to make algorithm to detect the waves and
exclusion of intermediary signals between the waves were not highly desired.
The mean signal of the independent leads were determined to detect the
time index of the peaks of P-, QRS-, and Twave for each person and each
measurements.
The QRS-segment was deﬁned as 70 milliseconds before and after the maxi-
mum value in the median beat. One sample corresponds to 2.4 milliseconds.
The start point of the ST-T segment was deﬁned as the end point of QRS-
segment plus one sample. And the end point was deﬁned as 192 milliseconds
after the maximum of T-wave.
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Figure 8.8: Figure shows an example of the time indexes of the independent mean beat
is given. Red upward triangles indicate the P-segment, green downward triangles
indicate the QRS-segment and the black upward triangles indicate the ST-T-segment.
The start point of P-wave was deﬁned as 108 milliseconds before the maxi-
mum of P-wave. The end point of P-wave was deﬁned as the start point of
QRS-wave minus one sample. In ﬁgure 8.8 an example of the time indexes
of the independent mean beat is given. Red upward triangles indicate the P-
segment, green downward triangles indicate the QRS-segment and the black
upward triangles indicate the ST-T-segment.
Segmentation of ECG
For each person and each measurements the time indexes of the P-, QRS-,
and T-wave were used to segment the independent leads, and an example of
the segmentation is shown in ﬁgure 8.9
Determination of regression coeﬃcients
Regression coeﬃcients for each posterior lead and for each segment was de-
termined i.e. 18 sets of regression coeﬃcients. The regression coeﬃcients
were determined according to expression 8.21.
Analysis of the magnitude range and segmentation
The ECG recordings of all subjects in the subset were merged into one large
data set and were considered as one data recording. The maximum and
minimum magnitude value of the pooled data set was found and graphically
depicted as ranges for all measured leads. Q-Q plots of the ECG data from
the 14 leads were generated and analyzed. To obtain a better approxima-
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tion to the normal distribution, the ECG's of the subset were segmented
into P-waves, QRS-complexes and T-waves, with respect to all leads. The
segmentation algorithm is described in citeandersen. The P, QRS and T
segments were pooled into large data sets, in correct subject order for the
14 leads. New Q-Q plots were generated and a better approximation to the
normal distribution was achieved. The means and the standard deviations
of the segments for the standardization procedure were determined.
Standardized beta coeﬃcients
Standardized beta coeﬃcients (SBC) are useful when comparisons of the
independent variables in the regression model are of interest. The SBC
are determined in the same matter as the regressions coeﬃcients derived in
formula 4, see [90]. However in the SBC model, the independent variables
are standardized in order to their mean and their standard deviation, as
follows:
zi,n = (xn − µi)/σi (8.25)
,where i denotes the number of the lead, and n the sample index. Next to
the standardization, partial regression models for each posterior lead and for
each segment were determined.
8.7 Data acquisition protocol
Background
Acute myocardial infarction (AMI) is one of the main leading causes of death
in the western countries [3]. AMI is a occlusion of the coronary arteries by
a thrombus, which cause necrosis due lack of blood perfusion. The main
symptom of AMI is severe pain in the chest region with radiation to the
upper limbs and neck [31].
The electrocardiogram (ECG) is a strong diagnostic tool in diagnosing AMI.
An occlusion of one of the coronary arteries is reﬂected in an ECG, as an
elevation of the isoelectric ST-segment. In order to the location of the oc-
clusion, ST-elevation will appear in diﬀerent leads on the ECG. Simpliﬁed
the occlusion can occur in; the left anterior descending branch (LAD), the
right coronary artery (RCA) or the left circumﬂex artery (LCX). Table 8.1
shows in which leads the ST-elevation will appear in order to the diﬀerent
locations of the thrombus.
According to the table 8.1, the presence of a thrombus in RCA or LCX
will cause a ST-elevation in the standard leads II and III. To diﬀerentiate













Table 8.1: The table is a simpliﬁed representation of the occurrence of ST-elevation in
diﬀerent leads in order to the location of the thrombus. In an occlusion of RCA the
ST-elevation is mostly represented in lead III. In an occlusion of LCX the ST-elevation is
mostly represented in lead II. [44]
between the two locations, it necessary compare the magnitude of the ele-
vation in the two leads. For an occlusion in RCA, the ST-elevation will be
most pronounced in lead II. For an occlusion in LCX, the ST-elevation will
be most pronounced in lead III. Less than 50 % of the patients with AMI in
LCX, present ST-elevation in ECG, therefore is ST-elevation in the lead III
not a clinically signiﬁcant ﬁnding of an occlusion of LCX [91,92]. Although
in clinical practice posterior leads are not used as standard.
The precordial leads V1-V6 are sensitive to diagnose an occlusion in LAD and
RCA, while an occlusion in LCX is insensitive to diagnose with the precor-
dial leads [9395]. Several studies had proposed extension of the standard 12
ECG with further three leads (V7, V8 and V9) to obtain better assessment of
the electrical activity of the posterior wall [80,96]. Additional posterior leads
are generally accepted as an improvement of the ECG as a diagnostic tool for
posterior wall infarction, as a consequence of the results from several studies
investigating the impact of adding posterior leads to improve the sensitive of
diagnosing occlusion in LCX [75, 8284, 97]. As a lack insuﬃcient mapping
(with 12-lead EGC) of the electrical activity of the posterior wall, some car-
diologists analyze possible ST-depression (indirect/inverse reﬂection) in the
precordial leads V3 and V4 [98]. This indirect use of V3 and V4 may indicate
further extension of the 15-lead ECG to 18-lead ECG, where the three new
electrodes (V10, V11 V12) are placed on the right lateral side of the back.
Despite the fact that the extended 15-lead (or further) ECG is more sensitive
to diagnose posterior wall infarction, only few ECG apparatus are dimen-
sioned for this purpose, and further there are some practical issues concerning
placement of the three additional electrodes on the back of a patient.
The aim of the study is to develop a mathematical model to derive the
posterior leads V7-V12 form a standard 12-lead ECG.
8.7. Data acquisition protocol 8. Method
Method
Sample size
In this study ECG's from a group of 30 healthy persons without any history
of heart diseases are included. The sample of the 30 persons must reﬂect
the variation in the population in order to diﬀerent kind of body shape, age
and gender. The persons included are students and employees at Institute
of Health Science and Technology, at Aalborg University.
Data acquisition
Before placement of the electrodes, cleaning of the skin with alcohol is re-
quired for better adhesion of the electrode. If the person is very hairy,
shaving the area may be necessary. Placement of the posterior electrodes is
done with the person standing. The placement of the precordial electrodes
is in supine position. The anatomical placement of the 8 standard electrodes
and the three additional posterior electrodes are listed below.
Right arm (RA) On right arm distal on radius.
Left arm (LA) On left arm distal on radius.
Left foot (LF) On left leg over lateral malleolus.
V1 Fourth intercostal space to the right of the sternum.
V2 Fourth intercostal space to the Left of the sternum.
V3 Directly between leads V2 and V4.
V4 Fifth intercostal space at midclavicular line.
V5 Level with V4 at left anterior axillary line.
V6 Level with V5 at left midaxillary line.
V7 Left lateral side of the back, over the posterior axillary line. (Same level
as V5)
V8 Left lateral side of the back, over the midscapular line. (Same level as
V5)
V9 Left lateral side of the back, half way between midscapular line and
spine. (Same level as V5)
V10 Right lateral side of the back, over the posterior axillary line. (Same
level as V5)
8. Method 8.7. Data acquisition protocol
V11 Right lateral side of the back, over the midscapular line. (Same level
as V5)
V12 Right lateral side of the back, half way between midscapular line and
spine. (Same level as V5)
The ECG monitor (Brand, sampling, resolution??) used in this study is
dimensioned for 12 channels, therefore only 15-lead ECG are available at
each recording. Since the desire is to derive the three posterior lead (V7-V9)
and the additional posterior leads (V10-V12) on the right side of the back,
the recording procedure is conducted in two trials. In the ﬁrst trial leads
V1-V9 are measured. In second trial the leads V7-V9 are moved form the left
side of the back to the right side of the back, and the leads recorded are
now V1-V6 and V10-V R12. For each trial, 10 recordings of 10 seconds are
acquired. During the recording the person is in a supine position, and can
breath normally, but no movements of the body are allowed to avoid noise
for the surrounding muscles.
Beside the recorded ECG, personal information as gender, birth day, weight
and height are registered.
Determination of the transformation matrix for the posterior leads
V7-V12
The linear transformation of the standard leads to the posterior leads is only
possible if the heart is assumed as a dipole with a ﬁxed location and variable
orientation and magnitude. The surrounding tissue e.g. lungs, adipose tissue
and bone together can be assumed as a inﬁnite homogenous conductor [87].
The recorded leads are a projection of the electrical resultant vector of the
heart on the lead vector formed by the location of the electrodes.
The electrical resultant vector of the heart is depicted as an yellow arrow, on
ﬁgure 8.10 top. The lead vectors are depicted as blue vector in the frontal
plane, bottom. The projections on leads I, II and III are marked with red
arrows. In matrix convention the projection is given as
v = lTRe (8.26)
where V is the matrix containing the recorded potentials, l is the denotation
of the lead vectors and are constant. Re is the electrical resultant vector of
the heart and is time dependant.
Since the Re is the underlying cause of the potentials measured on the sur-
face, it is valuable to determine Re for further calculations. By means of
three independent leads, it is possible to determine the magnitude of Re
8.7. Data acquisition protocol 8. Method
for diﬀerent time instance. Given that the l is column vector with three
elements, the Re is given by
Re = (LT )−1V (8.27)
where L = (lI , lII , lIII) and V = (vI , vII , vIII)T . By substituting Re in
equation 8.26 with equation 8.27
v = lT (LT )−1V (8.28)
m
v = aV (8.29)
In standard ECG only eight of the 12 leads are independent (I, II, V 1, . . .
V 6). Transforming this fact in to a in equation 8.29 yields
a = lT (LLT )−1L (8.30)
Determination of a can be performed by measuring the standard leads and
in our case the posterior leads V 7,. . .,V 12. Transforming formula 8.29 to a
computational equation yields
Vp = AVs (8.31)
where p and s refers to the posterior leads and standard leads, respectively,
and A contains the coeﬃcients of transformation. The only unknown in
equation 8.31 is ap,s.
A = (VTs Vs)
−1VTs Vp (8.32)
Statement of the matrix dimension
We expect the dimension of the matrix A must be 8x3, because we have
eight independent leads and desire to determine three unknown leads.
Let us assume that the Vs is of dimension nx8, where n is the number
of samples and the eight independent leads. Vp is of dimension nx3, the
three posterior leads. VTs is 8xn. Therefore the dimension of statement in
parentheses (VTs Vs)−1 is 8x8, dimension of VTstandardVp is 8x3. Then the
dimension of the matrix A in equation 8.33 is 8x8 · 8x3 = 8x3.
The deviation of the model
The evaluation of the transformation matrix, is made by a comparison of the
measured posterior leads and the derived posterior leads. For the measured
8. Method 8.7. Data acquisition protocol
posterior leads the average amplitude is determined. The average error of





(Vmeasured − Vderived) (8.33)
The average deviation is given as percentage error in order to the average
amplitude of the measured posterior leads. If Errorave = 0 then the model
is ideal.
8.7. Data acquisition protocol 8. Method
Figure 8.9: Figure shows an example of the segmentation of the independent leads.
Red upward triangles indicate the P-segment, green downward triangles indicate the
QRS-segment and the black upward triangles indicate the ST-T-segment.
8. Method 8.7. Data acquisition protocol
Figure 8.10: Schematic illustration of projection of the electrical resultant vector of the
heart on the lead vector. [40]
Chapter 9
Results
9.1 Analysis of correlation coeﬃcient
This chapter contain an overview of the results obtained in the analysis
of correlation of ECG data. The analysis is divided in a pooled and an
individual analysis. The contain of this chapter is as follows:
• Analysis of correlation coeﬃcient (CC), for pooled data
• Analysis of CC, individualized data
• Q-Q plots of CC,individualized data
9.2 Correlation coeﬃcient, for pooled data
In this analysis all the data is pooled, and each observation is assumed as
independent.
Figure 9.1 shows the CC for leads V7(blue circle), V8(red pentagram) and
V9(gray rectangle). Further the CC of the posterior leads are also shown.
Figure 9.2 shows the CC for leads V10(blue circle), V11(red pentagram) and
V12(gray rectangle). Further the CC of the posterior leads are also shown.
9.3 Correlation coeﬃcient, for individualized data
The ECG data is arranged in a (time x leads x subject) matrix. The CC's
are determined for the posterior leads on both sides.
Figure 9.3 shows the CC for leads V7(blue circle), V8(red pentagram) and
V9(gray rectangle), as an average. The 95 % standard deviation is given by
the error bars.
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Figure 9.1: CC of the posterior leads V7, V8 and V9. The data is pooled.



































































































Figure 9.2: CC of the posterior leads V10, V11 and V12. The data is pooled.




























































































































Figure 9.3: Average CC of the posterior leads V7, V8 and V9. The data is
individualized.
Figure 9.4 shows the CC for leads V10(blue circle), V11(red pentagram) and
V12(gray rectangle), as an average. The 95 % standard deviation is given
by the error bars.





























































































































Figure 9.4: Average CC of the posterior leads V10, V11 and V12. The data is
individualized.
9.4 Q-Q plots of CC,individualized data
The is Q-Q plots are used to determined whether the underlying distribution
of the individual CC's are normal distributed. The following six ﬁgures 9.5-
9.10 show the Q-Q plot of V7, V8, V9, V10, V11 and V12 in the mentioned


































































































































Figure 9.5: Q-Q plot of the CC's of the lead V7 and the standard leads.

































































































































Figure 9.6: Q-Q plot of the CC's of the lead V8 and the standard leads.
9.5 Characteristics of study group
In each sub-group 19 subjects were allocated, 6 females and 13 males. The
median age in the training group was 26 years and the median age in test
group was 24 years. The average height was equal in both group, while the
average weight was higher in test group then in the training group, 79 kg

































































































































Figure 9.7: Q-Q plot of the CC's of the lead V9 and the standard leads.
and 76.84 kg, respectively. The higher average weight in the test group is
reﬂected in the body mass index (BMI), 24.17 kg
m2
for the test group and
23.53 kg
m2
for the training group, see table 9.1.

































































































































Figure 9.8: Q-Q plot of the CC's of the lead V10 and the standard leads.
9.6 Multiple regression model
Table 9.2 shows the coeﬃcients of the transformation matrix for the multiple
regression model. Each coeﬃcients in the columns describes the weighting
of the speciﬁc independent lead in the regression model to obtain the depen-
dent leads (shown in the rows). To obtain the posterior leads V 7-V 9, the

































































































































Figure 9.9: Q-Q plot of the CC's of the lead V11 and the standard leads.
information from lead V 6 and to a certain extent also lead V 5 are of great
importance, while all other independent leads I-V 4, have modest contribu-
tion to the model. In determination of the dependent leads V 10-V 12 the
most inﬂuential independent leads were I, V 5 and V 6. The coeﬃcients of
the transformation matrix are also plotted in ﬁgure 9.11 for better graphical
overview.

































































































































Figure 9.10: Q-Q plot of the CC's of the lead V12 and the standard leads.
The median coeﬃcients of determination R2 of the six dependent leads are
given in table 9.3. In column two and three the median and the range
of R2 for the training group are listed. In column four and ﬁve the same
information is given for the test group. In both groups the highest R2 is
obtained for V 7. R2=0.98 for the training group and R2=0.96 for the test
group, respectively. R2 is decreasing toward V 9 in both group. For the leads
9. Results 9.6. Multiple regression model
Table 9.1: Summarization of subjects characteristics. * = Median/range
Training Test
Parameter Mean SD Mean SD
Female n = 6 n = 6
Male n = 13 n = 13
Age 26* 21-37* 24* 21-36*
Height 1.80 m ± 0.08 1.80 m ± 0.10















Transformation coefficients for leads V7−V9
 
 






Transformation coefficients for leads V10−V12
V12V11V10
V7 V8 V9
Figure 9.11: Graphical presentation of the coeﬃcients of transformation matrix.
9.7. Simple regression model 9. Results
Table 9.2: Transformation matrix, multiple regression model
I II V1 V2 V3 V4 V5 V6
V7 0.058 0.0121 -0.0289 -0.0092 -0.0126 0.0344 -0.35 1.0947
V8 0.0387 -0.0304 -0.0608 0.0123 -0.0755 0.106 -0.5717 1.2764
V9 -0.0423 -0.1009 -0.0999 0.0271 -0.1008 0.1345 -0.7423 1.3453
V10 -0.2257 -0.0542 -0.0812 0.0139 -0.0647 0.0794 -0.4287 0.5339
V11 -0.2916 -0.0008 -0.0323 0.0046 -0.0469 0.038 -0.2363 0.2661
V12 -0.3527 0.0582 0.0038 -0.0131 -0.0086 0.0061 -0.1355 0.1342
V 10-V 12, R2 is almost equal between the leads and also between the groups.
The values given in the table are truncated values.
9.7 Simple regression model
Simple regression of the standard leads and the posterior leads yielded the
coeﬃcients of determination r2, and are given in table 9.4. The transfor-
mation coeﬃcients are not shown. In reconstruction of the posterior leads
V 7-V 9 the standard leads II, V 2, V 5 and V 6 contribute with information,
while e.g. lead V 3 explains less than 15 % of the variance in the model. In
reconstruction of leads V 10-V 12, the standard leads I, V 3 and V 4 performs
well, while V 1 does not contribute with signiﬁcant amount of information.
The coeﬃcients in the table given in graphical presentation, for better overview.
Table 9.3: Coeﬃcients of determination, multiple regression model
Training Test
Lead Median (Range) Median (Range)
V7 0.98 (1-0.34) 0.96 (1-0.08)
V8 0.95 (1-0.59) 0.93 (0.99-0.06)
V9 0.88 (0.98-0.14) 0.87 (0.99-0.28)
V10 0.90 (1-0.25) 0.89 (1-0.03)
V11 0.91 (0.99-0.36) 0.91 (0.99-0.18)
V12 0.90 (0.98-0.17) 0.89 (0.98-0.06)
9. Results 9.7. Simple regression model
Table 9.4: Coeﬃcient of determination, simple regression model
I II V1 V2 V3 V4 V5 V6






































































































9.8. Beta coeﬃcients with interception 9. Results


















Figure 9.12: The coeﬃcients in table 9.4 shown as stem plots.
9.8 Beta coeﬃcients with interception
The ﬁgure 9.13 below shows the beta coeﬃcient when the regression is made
with interception. In this study, we constrained the model and let the inter-
ception be 0. β0 6= 0 do not make nay sense.





























































Figure 9.13: The coeﬃcients of the regression model with interception is shown.
9.9 Test of the independent variables
The aim of this test is to determine the statistical probability of the informa-
tion contribution of the independent leads. The test was conducted on the
9. Results 9.10. Stability
Subset R2 F-stat F-stat Param. P-
value
V6 0.978 1.24*109
V5 V6 0.988 1.55*109 4.87*105 ≤0.01
V1, V5, V6 0.990 1.39*109 1.13*105 ≤0.01
V1, V4, V5, V6 0.990 1.12*109 0.52*104 ≤0.01
V1, V2, V4,V5, V6 0.990 0.95*109 1.06*104 ≤0.01
V1, V2, V3 V4,V5, V6 0.990 0.82*109 8.13 ≤0.01
II, V1, V2, V3 V4,V5, V6 0.990 0.71*109 -0.85 ≥0.01
I, II, V1, V2, V3 V4,V5, V6 0.990 0.63*109 -1.49 ≥0.01
Table 9.5: Summary of statistics of lead V7
Subset R2 F-stat F-stat Param. P-
value
V6 0.936 4.13*106
V5, V6 0.965 5.20*106 4.73*105 ≤0.01
V1, V5, V6 0.974 5.34*106 2.02*105 ≤0.01
II, V1, V5,V6 0.974 4.35*106 9.50*106 ≤0.01
V1, V3, V4,V5, V6 0.975 3.66*106 6.68*103 ≤0.01
II, V1, V3 V4,V5, V6 0.975 3.24*106 1.61*104 ≤0.01
II, V1, V2, V3 V4,V5, V6 0.975 2.83*106 2.9*102 ≤0.01
I, II, V1, V2, V3 V4,V5, V6 0.975 2.51*106 -1.04 ≥0.01
Table 9.6: Summary of statistics of lead V8
six posterior leads. The combination of leads which contributed to the ﬁnal
model with signiﬁcant amount of information, was found iterative. First the
best subset of one independent variable was found. In next step the best
subset of two independent variables was found and so on to the end where
the model contained all independent variables. For each step the SSE (mean
square error in Matlab) was calculated.
The F-statistics was calculated for each time a new variable was added to the
model. If the F − statistics > FK1,n−K−1,α, then the statistical probability
of adding the new independent variable do not contribute with signiﬁcant
more information then the previous model is ≤ 0.01.
9.10 Stability
The aim this analysis was to investigate the stability of the regression coef-
ﬁcients of the linear regression model. The expectation is that at a certain
9.10. Stability 9. Results
Subset R2 F-stat F-stat Param. P-
value
V6 0.770 95376.976
V1, V6 0.867 1.23*106 4.13*106 ≤0.01
V1, V5, V6 0.903 1.32*106 2.10*105 ≤0.01
II, V1, V5, V6 0.910 1.15*106 4.63*104 ≤0.01
II, V1, V4,V5, V6 0.911 9.75*105 8.29*103 ≤0.01
II, V1, V3 V4,V5, V6 0.912 8.47*105 7.03*103 ≤0.01
II, V1, V2, V3 V4,V5, V6 0.913 7.43*105 1.14*103 ≤0.01
I, II, V1, V2, V3 V4,V5, V6 0.913 6.60*105 -1.40 ≥0.01
Table 9.7: Summary of statistics of lead V9
Subset R2 F-stat F-stat Param. P-
value
V1 0.750 8.52*105
V1, V4 0.763 6.11*105 3.18*104 ≤0.01
V1, V5, V6 0.785 5.19*105 5.81*104 ≤0.01
II, V1, V5, V6 0.793 4.36*106 2.26*104 ≤0.01
II, V1, V2,V5, V6 0.793 3.64*106 9.17*102 ≤0.01
II, V1, V3 V4,V5, V6 0.795 3.15*106 4.87*103 ≤0.01
II, V1, V2, V3 V4,V5, V6 0.795 2.76*106 2.73*102 ≤0.01
I, II, V1, V2, V3 V4,V5, V6 0.795 2.45*106 -1.15 ≥0.01
Table 9.8: Summary of statistics of lead V10
Subset R2 F-stat F-stat Param. P-
value
V1 0.845 1.55*106
V1, V4 0.852 1.09*106 2.86*104 ≤0.01
V1, V5, V6 0.858 8.63*105 2.49*104 ≤0.01
V1, V3, V5, V6 0.861 7.08*105 1.27*104 ≤0.01
V1, V3, V4, V5, V6 0.862 5.92*106 1.25*103 ≤0.01
II , V1, V3, V4, V5, V6 0.862 5.09*105 1.64*103 ≤0.01
II, V1, V2, V3, V4, V5, V6 0.862 4.45*105 -0.98 ≥0.01
I, II, V1, V2,V3, V4,V5, V6 0.862 3.96*106 -1.00 ≥0.01
Table 9.9: Summary of statistics of lead V11
9. Results 9.10. Stability
Subset R2 F-stat F-stat Param. P-
value
V2 0.869 1.88*106
II, V3 0.878 1.36*106 4.27*104 ≤0.01
II, V1, V4 0.882 1.06*106 18.20*104 ≤0.01
II, V2, V5, V6 0.885 7.31*105 1.66*104 ≤0.01
II, V1, V2, V5, V6 0.885 5.92*105 4.57 ≥0.01
II, V1, V2, V3, V5, V6 0.885 6.26*105 -0.99 ≥0.01
II, V1, V2, V3, V4, V5, V6 0.885 5.48*105 -1.00 ≥0.01
I, II, V1, V2, V3,V4,V5 V6 0.885 4.87*105 -1.00 ≥0.01
Table 9.10: Summary of statistics of lead V12
point, the beta coeﬃcients will stabilize. Behind the number of patients, the
model is stable, and the small variations in the coeﬃcients can be attributed
to random variation. When the coeﬃcients are stabilized the one of the
numerous solutions to the problem is obtained [99]. Small ﬂuctuations will
always appear, but it do not mean that a larger populations is needed to
obtain statistical stability [99].
The analysis was conducted for the six posterior leads. The analysis was
based step wise addition of more ECG data. For each step a new subject
was added and the regression coeﬃcient for the six posterior leads were
determined. The ﬁrst 19 subjects were subject included in the training group
and subjects 20-37 were subjects included in the test group.






















Figure 9.14: Development of regression coeﬃcients for predicting posterior lead V7.
9.11. Results of the average regression model 9. Results
























Figure 9.15: Development of regression coeﬃcients for predicting posterior lead V8.




















Figure 9.16: Development of regression coeﬃcients for predicting posterior lead V9.
9.11 Results of the average regression model
In table 9.11, the regression coeﬃcients for the average regression model is
given.
In ﬁgure 9.20, the regression coeﬃcients are given as bars for better graphical
overview.
In ﬁgures 9.21-9.23, the 19 diﬀerent coeﬃcients for the independent variables
for predicting the posterior leads V7-V12 are given.
In table 9.12, the performance of the pooled and the average method are
given.
In ﬁgures 9.24-9.26, the results of the reduced average models are shown.
9. Results 9.11. Results of the average regression model





















Figure 9.17: Development of regression coeﬃcients for predicting posterior lead V10.
























Figure 9.18: Development of regression coeﬃcients for predicting posterior lead V11.
βI βII βV 1 βV 2 βV 3 βV 4 βV 5 βV 6
V7 0.0811 0.0453 -0.0517 -0.0015 0.0128 -0.1048 0.0785 0.6580
V8 0.0797 0.0591 -0.0969 0.0345 -0.0416 -0.0999 -0.0489 0.7151
V9 0.0072 0.0643 -0.1438 0.0738 -0.1129 -0.0509 -0.2547 0.7611
V10 -0.2850 -0.1304 -0.1396 0.0712 -0.1280 0.0364 -0.2427 0.5339
V11 -0.3370 0.1343 -0.0774 0.0185 -0.0493 0.0081 -0.1512 0.0684
V12 -0.3936 0.1463 -0.0273 -0.0151 -0.0008 0.0037 -0.1411 0.0652
Table 9.11: Regression matrix, average regression model
9.12. Results of the analysis of the global model vs. partial models 9. Results





















Figure 9.19: Development of regression coeﬃcients for predicting posterior lead V12.












Regression coefficients for leads V7−V9, average model












Regression coefficients for leads V10−V12, average model
V8 V9V7
V10 V11 V12
Figure 9.20: Graphical presentation of the coeﬃcients of regression matrix.
9.12 Results of the analysis of the global model vs.
partial models
In ﬁgure 9.27 and 9.28, the results of the simple regression of the leads V5
and V7/V12 are given.
The results of table 9.13 are given in ﬁgure 9.29 for better graphical overview.
The median residuals of the partial models (solid lines) and the median
residuals for the global model (given as dashed lines).
9. Results 9.13. Standardized beta coeﬃcients







Dispersion of the regression coefficients of V7








Dispersion of the regression coefficients of V8
Figure 9.21: Dispersion of the regression coeﬃcients of leads V7 and V8.








Dispersion of the regression coefficients of V9







Dispersion of the regression coefficients of V10
Figure 9.22: Dispersion of the regression coeﬃcients of leads V9 and V10.
9.13 Standardized beta coeﬃcients
Range of the magnitude
In ﬁgure 9.30, the ranges of the magnitudes of all measured leads are given.
The magnitudes are given in an arbitrary unit. The largest ranges are found
in the standard leads V2-V4 and the smallest ranges are observed in the
9.13. Standardized beta coeﬃcients 9. Results







Dispersion of the regression coefficients of V11







Dispersion of the regression coefficients of V12































Dispersion of the regression coefficients of V7
Figure 9.24: The average regression coeﬃcients and the dispersion of the regression
coeﬃcients of leads V7.
posterior leads V10-V12. The displacement of the ranges with respect to
zero indicates the upward or downward direction of the QRS-complex.
In ﬁgure 9.31 left subplot, the data points of the standard lead V6 are plot-
ted against the data points of the posterior lead V7. These two leads are
neighbouring leads and measure almost the same signal and are therefore
highly correlated [90]. We can assume the ratio of their output spans (out-































Dispersion of the regression coefficients of V8
Figure 9.25: The average regression coeﬃcients and the dispersion of the regression
































Dispersion of the regression coefficients of V9
Figure 9.26: The average regression coeﬃcients and the dispersion of the regression
coeﬃcients of leads V9.
put ratio) to be one. In right subplot, the data points of the standard lead
V4 are plotted against the data points of the posterior lead V10. These leads
are measuring the electrical potential on opposite sites of the heart. They
can truly be highly correlated [90], however the output ratio is ¿ 1. The
data points of the three segments P (red), QRS (blue) and T (yellow) are
colour coded in the ﬁgure.





























































































Figure 9.28: The ﬁgure shows the results of the simple regression of the leads V5 and
V12.
Standardized regression coeﬃcients
Figure 9.32 shows examples of the Q-Q plots of un-segmented ECG and
segmented ECG. First column shows an example of Q-Q plots of the un-
segmented ECG of the standard leads; I, II and V4. From column one, we
see a highly tailed distribution of the three standard leads. And the Q-Q
9. Results 9.13. Standardized beta coeﬃcients



















Figure 9.29: The ﬁgure shows the results of the simple regression of the leads V5 and
V12.











Magnitude ranges of the independent leads
Figure 9.30: The ﬁgure shows the ranges of the magnitudes of all measured leads.
plots may suggest that the un-segmented ECG's are piece wise normally
distributed. In columns 2-4 Q-Q plots of the segments P, QRS and T of
leads I, II and V4 are given. Only a limited range of data is shown.
Figure 9.35 and 9.36 shows the magnitude of the SBC as bars for the three
segments for predicting the posterior leads V7-V12. To obtain the posterior
leads V7-V9, the absolute values of the SBC of leads V5 and V6 are of
9.13. Standardized beta coeﬃcients 9. Results
4000
Outout range of V6














Output range of V4 vs. V10
Figure 9.31: In the left subplot, the data points of V6 are plotted against the data
points of V7 and in right subplot, the data points of V4 are plotted against the data
points of V10. In the left subplot the output ratio is ? 1 and in the right subplot the


















Figure 9.32: The ﬁgure shows the Q-Q plot of the standard leads; I, II and V4. First
column shows the Q-Q plot of un-segmented ECG's. Columns 2-4 show the Q-Q plot of
the three segments P, QRS and T, respectively.
greatest magnitude. In the determination of the posterior leads V10-V12,
the absolute values of the SBC of leads I, V 5 and V 6 are of greatest
magnitude.
9. Results 9.14. Results of regression of the P-, QRS- and ST-T- segments





Regression coefficients for leads V7−V9 of segment P





Regression coefficients for leads V7−V9 of segment QRS















Figure 9.33: The ﬁgure shows the magnitude of the SBC of the partial regression
models for leads V7-V9, plotted as bars.





Regression coefficients for leads V10−V12 of segment P





Regression coefficients for leads V10−V12 of segment QRS









Figure 9.34: The ﬁgure shows the magnitude of the SBC of the partial regression
models for leads V10-V12, plotted as bars.
9.14 Results of regression of the P-, QRS- and ST-
T- segments
A graphical plot of the regression coeﬃcients are shown in ﬁgure 9.35 and
ﬁgure 9.36
The results of the segment wise regression do not diﬀer form the regression
9.14. Results of regression of the P-, QRS- and ST-T- segments 9. Results





Regression coefficients for leads V7−V9 of segment P





Regression coefficients for leads V7−V9 of segment QRS















Figure 9.35: Figure shows the regression coeﬃcients of the segments P, QRS and ST-T
in the posterior leads V7-V9.





Regression coefficients for leads V10−V12 of segment P





Regression coefficients for leads V10−V12 of segment QRS









Figure 9.36: Figure shows the regression coeﬃcients of the segments P, QRS and ST-T
in the posterior leads V10-V12.
of the entire signal. The most dominating leads are still V 5 and V 6 in the
posterior leads V 7-V 9 and in the posterior leads V 10-V 12 the dominating
independent leads are I, V 5 and V 6.
9. Results 9.14. Results of regression of the P-, QRS- and ST-T- segments





V7 0.98 (1.00-0.95) 0.58 (0.97-0.19)
V8 0.96 (0.99-0.92) 0.52 (0.91-0.14)
V9 0.95 (0.99-0.91) 0.40 (0.75-0.05)
V10 0.81 (0.90-0.71) 0.32 (0.68-0.00)
V11 0.82 (0.92-0.73) 0.31 (0.66-0.00)
V12 0.85 (0.93-0.77) 0.30 (0.61-0.00)
Table 9.12: Coeﬃcients of determination R2 of the pooled and the average method.
9.14. Results of regression of the P-, QRS- and ST-T- segments 9. Results
Pooled Average
Lead Median(Range) Median(Range) p-value
P -10.24 (-26.91-
6.43)
-0.13 (-3.67-3.40) p < 0.05







-0.68 (-6.24-4.88) p < 0.05
P -9.61 (-26.48-
7.25)
-0.20 (-3.98-3.58) p < 0.05







-2.29 (-9.28-4.69) p < 0.05
P -3.07 (-15.65-
9.50)
-0.54 (-5.54-4.46) p < 0.05












1.49 (-5.14-8.14) p < 0.05












1.43 (-4.67-7.54) p < 0.05







-0.47 (-8.25-7.31) p < 0.05
P -2.96 (-15.96-
10.03)
-2.68 (-3.97-7.28) p < 0.05







-0.14 (-7.16-7.46) p < 0.05
Table 9.13: Residuals of the global model and the partial models.
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